Podcasts about Grouse

Orvis-endorsed guide Michael Browning of Grouse Haven Wing-Shooting takes us into the Maine woods for a tutorial on all things ruffies and timberdoodles. From the birds' daily schedule to good habitat types, he's got decades of experience in the deep woods. Well, not so deep. That's one thing we'll learn about habitat. We also explore how to handle our dogs in the forest, being a good guide client, bird behavior, finding public ground, and get a few dog-training insights. "Fix It" reminds us of another important date for walk-in hunters, and listeners share their "lightbulb people" ... the ones who started their bird-hunting adventure and why. And it's all brought to you by: Mid Valley Clays and Shooting School, CableGangz, TrulockChokes, Pointer shotguns, USA Clay Target League, Purina Pro Plan Sport and FindBirdHuntingSpots.com.

Close your eyes and let yourself be transported to the shore of a Nordic forest lake at the exact moment spring takes hold. As the sun rises slowly over the horizon, painting the landscape in soft light, the trees and bushes begin to turn green in the fresh morning air. This authentic and unedited recording offers a perfect immersion into nature's own symphony.The sophisticated, flute-like song of the blackbird opens the morning, while the rhythmic and almost hypnotic bubbling of black grouse lekking continues steadily in the background. From the reeds of the lake, the croaking of frogs creates a low and soothing undertone for the entire soundscape. This experience is completed by the virtuoso melodies of the song thrush, and at certain moments, you can hear the distinctive, haunting calls of curlews as they fly high above the water.This natural soundscape is designed specifically for deep relaxation, stress relief, and sleep support. It also works perfectly as a background for focused work or study, effectively masking distractions and bringing the peace of a northern spring directly to your headphones. Use this recording for meditation, unwinding, or a momentary escape from the rush of daily life.Keywords: spring, nature sounds, black grouse lek, birdsong, relaxation, sleep sounds, Nordic nature, ambient, forest, lakeside, meditation music, deep sleep.

Palliative care in multiple sclerosis spans the disease course, from early screening and support after diagnosis to symptom management and quality‑of‑life optimization in midstage disease, and end‑of‑life care in advanced MS. This episode outlines a staged approach to palliative care, highlights the roles of neurology and primary care teams, and discusses tools such as patient‑reported outcomes and symptom scales to support ongoing assessment of patients and care partners. In this episode, Katie Grouse, MD, FAAN, speaks with Penelope Smyth, MD, FRCPC and Janis M. Miyasaki, MD, MEd, FRCPC, coauthors of the article "Palliative Care in Multiple Sclerosis" in the Continuum® April 2026 Multiple Sclerosis and Related Disorders issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. Smyth is the director of the Division of Neurology in the Department of Medicine at the University of Alberta in Edmonton, Alberta, Canada. Dr. Miyasaki is a professor in the Division of Neurology in the Department of Medicine at the University of Alberta and the zone clinical department head for Clinical Neurosciences at Alberta Health Services in Edmonton, Alberta, Canada. Additional Resources Read the article: Palliative Care in Multiple Sclerosis Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Grouse: With the new treatments for MS, people might be saying palliative care is not relevant at all. It's about giving up hope and hopelessness. But this article covers why palliative care is important for your patients and families throughout their illness trajectory. Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Grouse: This is Dr. Katie Grouse. Today, I'm interviewing Drs Penelope Smyth and Janis Miyasaki about their article on palliative care in multiple sclerosis, which appears in the April 2026 Continuum issue on multiple sclerosis. Welcome to the podcast, and please introduce yourselves to our audience.  Dr Smyth: Thank you, Katie. I'm Penny Smyth. I am a neurologist at the University of Alberta, a professor in neurology, and a clinical multiple sclerosis specialist.  Dr Miyasaki: Hi, Katie. Thanks for having us. I'm Janis Miyasaki. I am a movement disorder neurologist primarily who also provides neuropalliative care at the University of Alberta in Edmonton, Canada.  Dr Grouse: It's so great having you today to talk with us about your article. I thought this article was really a wonderful take on the topic. I learned a lot, and I'm really hoping all of our listeners will take advantage of this article and take advantage of all the learning they can get from reading about this topic. So, I wanted to start with a more general question, which is, what is the key message from this article that you're hoping your readers will take away?  Dr Smyth: In terms of key takeaways, I think it's our hope that neurologists will come away from reading this article with, really, an expanded understanding of what palliative care is and how that might be applicable to them in their care for their patients with MS along a continuum of treating people with MS, that there can be components of palliative care and strategies that can be integrated early after diagnosis in, really, anywhere along the continuum of caring for people with MS. We've called that kind of mid-stage. And then there are particular needs for people with MS and their care partners in late-stage or severe MS and end of life that might require different palliative care strategies. I think we kind of have maybe a bit of a bias sometimes in thinking of palliative care as more directed towards those that are near end-of-life. But in fact, it's a much expanded concept.  Dr Miyasaki: And I'll just add that we also discuss a palliative approach, that palliative care skills and philosophies can be used by generalists---in this case, neurologists who are providing care to people with MS---and that adopting certain skills and communication techniques can help us better address our patients' and their families' symptoms. And also to keep in mind that for most people with neurologic illness, the unit of care is not only the patient, but it's the patient and the family, however that family looks.  Dr Grouse: Now, Penny, I'm curious, how are early-stage and mid-stage multiple sclerosis palliative care strategies different from, say, a typical evaluation and counseling that a neurologist would give, say, an MS specialist or even a general neurologist?  Dr Smyth: Thank you, Katie. That's a great question, and something that actually I learned in writing this piece with Janice and from her as a neuropalliative care expert. I think in terms of early strategies around palliative care that can be helpful to the general neurologist in their office, palliative care is about holistic support for patients and their care providers spiritually, emotionally, physically. There are components of palliative care and symptom management and making sure that the patient is at the center of the care, as well as support for their care partners with their holistic approach of relief of suffering as well as offering hope. When I started this piece, I was thinking that many of us neurologists, I think, often informally utilize many of these components already when we're dealing with patients early on after diagnosis in terms of communication, counseling, and education; going through their fear of an uncertain future; spiritual well-being; and then connecting them with supports for adaptive coping strategies. And then as well in mid-stage, which is really around what we can do in symptom management and improving quality of life, with screening tools and patient-reported outcome measures. However, I have to say that there are many unmet needs for people with MS and their care partners that they identify that are clearly not being met by us neurologists in this day and age. So even though we may be incorporating some of these strategies, I don't think we're meeting the mark all the time and hitting the target, especially in our busy office practices, in various ways. Dr Grouse: Given that, at a high level, what are some important early-stage MS palliative care concepts that we should be keeping in mind when we are counseling patients in these stages of the disease? Dr Miyasaki: An important concept to keep in mind for neurologists dealing with early-stage MS patients is that for us, we feel successful that we have made a diagnosis. And yet for the patient, it is taking away that hope. Maybe it's not MS. Maybe I just have a numb hand and it's gonna go away. And for us to appreciate that while we make this diagnosis multiple times a week---or, for MS specialists multiple times a day---for this person, it is the first time, the first experience, and it shakes their entire foundation of who they are as a person, how they will perform all the tasks and roles that they have in society, in their professional lives, in their family structures, and in their close, intimate relationships. As physicians, we may be overwhelmed by acknowledging that. I feel that it's important for us to understand the needs that our patients have and to allow them to have their feelings. You know, feelings can feel messy and time-consuming, and yet when we fully see our patients, I feel that this is the best of medicine. And it certainly is, in terms of palliative care, the principle that we seek. We accept all of the patient, the joy and the sorrow, the anger and the frustration. We accept it all, and we try to determine what will serve this person who is suffering in front of us now.  Dr Smyth: There's another piece to this, which came up as Janice and I were writing together. We were talking about offering a prognosis to a patient as to how they would do, and this was something that I thought deeply about, because I said, we always communicate how uncertain the prognosis is and how we can't predict the future. And then she said to me, well, what about offering a roadmap to a person with MS soon after diagnosis as to how you're gonna determine how they do over the next couple of years? Which are really important years in terms of determining how patients are doing on their disease-modifying therapies, whether they're having progression or not, and things. It's a pivotal time. So, if you can offer a roadmap to a person with MS and say, look, this is when we will be following you up. This is how we will be following you with MRI and biomarkers if you have that available, and this is how we will determine how responsive you are and then how we move forward from there. Dr Grouse: Really important concepts. And the roadmap certainly makes a lot of sense to me and something that, apart from just being useful to the patient for so many reasons to help set expectations, you know, is useful for us to better partner with the patient so they understand this is sort of how we do things and everyone's sort of expectations are met. So, I think those sound like really great goals and things to keep in mind. Now, we talked about early-stage MS palliative care concepts. How does that change as you get into the mid-stage of the disease?  Dr Smyth: Yeah. So, this is reflecting the fact that the course of MS is so different and the experience of MS is so different person to person. And so, what do we do as neurologists when we follow these people long-term over years and decades of living with their MS as their needs evolve, as their symptoms evolve, and as their disability evolves? Well, really, this is about the time of getting into, what are the symptoms that they're struggling with, what are the causes of their suffering at various points? And then how do we identify that, maybe with use of patient-reported outcome measures, screening scales, things like that. And then how do we direct symptomatic management to the specific symptoms that are causing distress to the patient? As well as trying to improve their quality of life in various ways, treating their comorbidities, making sure to check on exercise, healthy living, and that kind of thing.  Dr Grouse: Now getting into, I think, topics that we're more used to thinking about when we think about palliative care: a lot of us, I think, are really unsure of the right time to discuss advanced care directives in the course of multiple sclerosis, and I think that's not helped by the fact that many of us are just, in general, not terribly comfortable talking about those types of things in general. What is your advice to questions like this?  Dr Smyth: And this is something that, again, Janice and I had to come together on, because there is no universal accepted time for when is the right time in multiple sclerosis to discuss advanced care directives and goals of care. And in fact, when they have looked at it in the literature, different things have come out. It has come out that neurologists can be uncomfortable discussing this. There's unique challenges to people with MS in that they have a diagnosis at a young age with an uncertain trajectory of how their course of disease is going to go. And many of these things lead care providers to be somewhat hesitant as to when is the right time, as well as, there were identified barriers within patients themselves as to when the right time might be to discuss. In that, you know, some of the coping strategies might be, as identified by some of the qualitative studies that have been done on this, around the fact that they would prefer to focus on the present rather than the future. In some studies expressed an ambivalence as to when they thought the right time might be, as well as some negative experiences that they might have had from providers trying to discuss these things in their previous experience. So, I went back to looking at the European guidelines for palliative care in MS, who suggested when a person might have severe MS---which they define as walking with bilateral aids for at least twenty meters or an EDSS of six or higher---or trigger-based, when there has been a change in the patient's status, when there's been a decline in some way or progression. Now, this is a little different, actually, than what we offer other people with neurologic diseases, and I don't know if that's the right answer. And this is where I'm going to turn it over to Janice, because I think we could learn something, as neurologists who treat people with MS, from our palliative care specialists.  Dr Miyasaki: I think of advanced care planning in a very different way. I think what a lot of the patients were expressing in the studies was that being asked about advanced care planning signaled to them in some way that they have reached this point in their illness where things aren't going so great and I anticipate that you may run into complications. Whereas in our movement disorder clinic, one of our fellows did a study looking at capacity for decision-making. And even in people who scored normally on the Montreal Cognitive Assessment, they had impairments in some of the domains of decision-making. And so, our philosophy in movement disorders at least---and some of our patients are quite young who have multiple system atrophy, they could be in their forties---we take the philosophy that everyone over the age of decision-making capacity, which is generally eighteen, should have some goals of care established. And how I introduce it in my clinic is, you know, for the young resident, you want the full-meal deal, because the likelihood of the resident surviving the ICU admission is very high. And then when we look at me, who… I am older, the likelihood of surviving an ICU admission is considerably lower. And so, the appropriate goals of care might be that I am willing to go to the ICU, and if things go well, then they can continue. But if things are not going well, they can have a discussion with my personal directive or power of attorney to talk about what the goals of care should be. And then the other aspect is sometimes having the conversation with family is really important because most of our families in hospital express an uncertainty. Am I doing the right thing? And they want to do the right thing for their loved ones. And most people actually say, if you ask them, I don't want to burden my family with making decisions that are going to tear at their hearts. So, then we can't actually make good informed decisions for our loved ones unless we have clear conversations. I think it does speak to our superstitious beliefs that if we talk about death, it's going to happen. But I hope the listeners will take my word for it, it really doesn't. And someone had a really good saying about the advanced directive. They're kind of like evening clothes. You should take them out every once in a while and make sure they still fit. And so, when you normalize it in this way, it helps people to just say, oh, yeah, it's once a year. Dr. Miyasaki is gonna ask me about how do I feel about those goals of care. And then it doesn't have this portent of, oh, I'm not doing well. Instead, it's just, this is what we should all be doing for our sake and for our family's sake.  Dr Smyth: Now, one thing that I have to add on to this is that it is important to try to establish advanced care directives before patients experience cognitive decline, because then that can make it a much more challenging conversation and brings nuances of challenge into the interactions, which, you know, are hard.  Dr Grouse: And Penny, I'm glad you brought that up, because I was really struck by that point too when reading this article, how easy it is to miss the subtle signs that cognitive changes are happening. I think it's just- it's a good kind of segue into that topic in general, but it is such an important link to, you know, making sure that you get those advanced directives at a time when the patient's really able to express and understand what they're talking to you about. Now, on the topic of the cognitive screenings, what's a good way to do this type of screening, and why is this type of screening so particularly important in the case of multiple sclerosis?  Dr Smyth: Yeah. Thank you, Katie. I think that it's important for our listeners to think about and recognize when we see our patients with MS because it is one of the invisible symptoms that people with MS can live with and may not be apparent on regular conversation in the office. So, it's important to deliberately ask about subjective challenges in cognition. Ask the partner about how they're doing in terms of their cognition in various ways. As well as asking them and exploring then, how are they doing in their professional roles if they're working or in their surroundings? How are they coping on a daily basis on a cognitive level in addition to a physical level? We know that cognitive issues are actually the biggest contributor for not working and are a huge driver of disability in MS in terms of functioning, even more than physical decline in many ways. So, it is important for us neurologists to keep top of mind and to think about and deliberately attend to. There are screening tests that we can do in the office. The easiest for us, which measures the verbal processing speed, is the SDMT test, which is a ninety-second test matching symbols and numbers. It's easy to do. You can train a MOA to do it before you see the patient and things like that, and it just gives you an idea as to where the patient is at. And usually they're having difficulties if they're greater than two standard deviations below the norm for their age, or if there's a significant drop of four or eight points, and that might signal to you that there might be more going on. You can explore it, and then if you do have this available, the ability to refer for neuropsychological testing if there's questions. But often we can't get it with the MoCA score, unfortunately.  Dr Grouse: Talking about all these concepts, I think they all sound great. I think a lot of us hearing this will naturally say, "Yes, these are absolutely things we should be incorporating in the care of these patients." What I wondered about was, certainly we're all very busy, it is really hard to find time for a lot of these things. We don't always have access to specialists who can help us with some of these conversations. How can we find time, and how can we work this into the care of our patients effectively and still make time for all the other things we have to talk about, and make sure that we're seeing all of our other patients and staying on time and all of those things?  Dr Miyasaki: Yes. I think that's the challenges of dealing with people who actually, over time, their care needs increase, is huge in neurology. I can't think of a single subspecialty where care actually gets easier. It's constantly getting harder. You know, having come from private practice, I completely understand my colleagues' challenges in the community. Some of the ways that other groups have managed this when they don't have government or university support in their center is actually to look at not-for-profits. There are a lot of not-for-profits that can help in terms of wayfinding for social services, explaining to the patients and the family what is available to them. And in fact, some of them can also provide some cognitive supports, as well as point them in the way of day programs. And many of them have very established caregiver support groups, as well as patient support groups for various stages of their illness. So, I think it requires for the individual or small or even a large group practice to be inventive, to look in your community and see what resources are available and free for your patients in order to establish that loose team without boundaries to help your patients. Of course, for those in academic centers, I know that times are tight for all of us, and if you haven't established a team, it is a challenge; and then learning how to write a business plan or a briefing note for your institution and to learn how to speak the love language of administrators, is really key to putting forward the needs of our patients. Which, compared to heart attack patients or hips and knees, they are very rare, and yet our patients can result in significant cost to the healthcare system. So, we do have an opportunity to make the case that putting a little bit of investment in the ambulatory setting can result in significant cost savings to the system when it comes to acute care hospitalization.  Dr Smyth: So, I was thinking, Janis, as you were talking about that, when you were talking about not-for-profit groups, it's really the MS societies in various countries that are very active in this and have a lot of resources available, especially for care partners.  Dr Grouse: Those are really great tips. Thank you for bringing those up as potential other resources we can take advantage of. I wanted to ask specifically about physician-assisted death and assisted suicide, which certainly does come up, especially in later-stage parts of the disease. How can palliative care specialists be helpful when patients do express interest in these types of interventions?  Dr Miyasaki: As you know, Katie, in Canada, we've had a legislative right to access to what we call medical assistance in dying. When the legislation passed, one of my other colleagues and I felt that these were the only conversations we were having with our patients. In all this experience, I have sort of developed in my mind a framework of people who are what we call MAID-curious. They want to know what their rights are and how it would look, when they feel the time is close, for them to exercise that right. And then there are those who are fearful of future suffering. And some of them may have a very unrealistic view of what the future will look like. And this may be in particular for multiple sclerosis because many of the public's view is based on what treatment was like thirty years ago. It may not be informed by more recent treatment where patients actually do quite well, and the majority never get to progressive MS. And so, to explore and be open to that request is the first thing that is important. And then if the person has unresolved symptoms that, traditionally, we can't care for, the palliative care specialist can be very helpful because they just have inventive ways of looking at things. They look at it outside the box, and they have a different toolkit available to them. I would not want all neurologists to just send all these patients requesting physician-assisted death to their palliative care colleagues. But I think for those who are having unaddressed symptoms, it can be very helpful. Certainly, if there is an acute event in the hospital, then this is a time of crisis. And often hospitals will have an in-hospital palliative care team who can come and speak to the patient about what is going on and address some of their needs. And I would also like to emphasize the importance of spiritual care, because for many of our patients, they are not just having the physical suffering, they are also having the spiritual suffering of hopelessness or of feeling that they are a burden or that they just are not seen because a lot of the symptoms in MS are invisible. To have that understanding by a spiritual care counselor is really helpful for the people to feel understood and to reduce some of that suffering.  Dr Grouse: That's a really great point, I think, to end on, and I think it really ties in a lot of the themes that we've been talking about today. Thank you so much for coming to talk with us today. It's been such a pleasure having you both here. Dr Smyth: Thank you. Dr Miyasaki: Thank you, Katie. Dr Grouse: Again, today I've been interviewing Drs Penelope Smyth and Janis Miyasaki about their article on palliative care in multiple sclerosis, which appears in the April 2026 Continuum issue on multiple sclerosis. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Many thanks to Stacy Hornemann for the conversation and opportunity to taste current offerings at Blue Grouse Winery. The views from their reception centre are stunningly perfect. You could spend the day just looking out over the vines to the mountains beyond. But - of course - you are here to sample Ortega, Bacchus, Chardonnay, Pinot Noir, and other varieties that have been captured and bottles for today's and future enjoyment. This is a destination to put on your agenda when visiting Vancouver Island.

The New Blue Grouse with Winemaker Stacy Hornemann   Two Words – Blue Grouse Two More – The Cowichan. Last Two – Stacy Hornemann. When the legendary Jackson Family in Santa Rosa, in the heart of Sonoma County, California decided to add two Canadian wineries to their portfolio, they chose two on Vancouver Island. Unsworth... The post May 2nd, 2026- The New Blue Grouse with Winemaker Stacy Hornemann appeared first on Mulligan Stew.

Wildlife habitat is disappearing across Appalachia—and most hunters don't realize why. In this episode, we sit down with Eric Long and Cody Altizer to break down the real reason behind the decline, why “healthy forests” might actually be part of the problem, and what it's going to take to bring grouse back. We also dive into their new nonprofit, the Give for Grouse Initiative, and how they plan to make real impact through habitat work, education, and boots-on-the-ground conservation. If you care about wildlife, habitat, and the future of hunting, this is a conversation you need to hear. Sit back, relax, and enjoy the show.0:00 - Why Grouse Are Disappearing20:00 - Give for Grouse Mission33:34 - How Whitetails Took Over (Restocking History)36:31 - Michigan's 1-Buck Rule… Good or Bad?42:40 - Missouri Might Limit Non-Residents58:43 - Inside Deer Management Consulting1:10:04 - Filming Hunts1:34:02 - How Give for Grouse Started1:45:10 - Why Cutting Timber Creates Habitat2:14:14 - Are Conservation Groups Missing the Mark?2:57:03 - The Plan to Fix Grouse in AppalachiaCheck out Give for Grouse:https://www.facebook.com/GiveforGrouse/https://www.youtube.com/@UCfjOVyRF0b1OKPnL7yzkUNw https://www.instagram.com/give_for_grouse/SUBSCRIBE TO THE CHANNEL:https://www.youtube.com/c/HUNTRTUBEShop HUNTR Merch:https://wearehuntr.com/HUNTR Podcast is presented by:Hoyt Archery: https://hoyt.com (Code HUNTR for 20% off apparel)DeerGro: https://www.deergro.com (Code HUNTR for 15% off)Predator Camo: https://www.predatorcamo.com/ (Code HUNTR for 20% off)Beast Broadheads: https://beastbroadheads.com/ (Code HUNTR for 10% off)Lone Wolf Custom Gear: https://www.lonewolfcustomgear.com/ (Code HUNTR for 10% off your first purchase)RackHub: https://www.rack-hub.com/huntr (Code HUNTR for 10% off)Pure Wildlife Blends: https://www.purewildlifeblends.com (Code HUNTR for 10% off)Primos: https://www.primos.com/ (Code HUNTR for 15% off)Bushnell: https://www.bushnell.com/ (Code HUNTR for 15% off)HHA: https://www.hhasports.com/

Jeremiah Psiropoulos discusses updates from his guiding business and talks about birding in Colorado.

In this episode of Leupold's Hunt Talk Radio, Randy interviews Ted Koch, Executive Director of the North American Grouse Partnership, about the rapid decline of prairie grouse, particularly the Lesser Prairie Chicken, due to large-scale grassland loss. They discuss how most remaining habitat is on private land, where economic pressures often discourage conservation even among landowners who value it. Rather than relying only on regulation through the Endangered Species Act, they advocate for market-based incentive alignment that pay ranchers for ecosystem services like habitat, water, and soil health. Long-term conservation success depends on keeping ranching viable while working collaboratively with private landowners. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Pennsylvania Woodsman, Mitchell is joined by Tom McPherson, a diehard grouse hunter from western Pennsylvania, for a deep dive into one of the most challenging — and rewarding — pursuits in the upland woods. Tom shares how his passion for grouse hunting developed over time, eventually leading him into running bird dogs and traveling across the Northeast and upper Midwest in search of better bird numbers. The conversation explores the unique nature of grouse hunting, from unpredictable flushes and fast shooting to the role of dogs in locating birds that often prefer to run instead of fly. The discussion also takes a deeper turn into habitat, conservation, and the long-term outlook for grouse in Pennsylvania. Tom explains how timber management, forest age diversity, and large-scale habitat work — often supported by organizations like the Ruffed Grouse Society — are critical to sustaining and rebuilding populations. From breaking down maps and identifying productive cover to committing nearly year-round effort for a six-week season, this episode highlights the dedication required to chase grouse and the bigger picture of habitat stewardship that supports the future of the species.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode of the Wildtalk Podcast, Eric and guest host Fahimeh Baziari start of the show with some background on costal plain marshes. That's followed up with a chat about the spruce grouse, before finally flying into the world of the Indiana bat. Episode Hosts: Fahimeh Baziari and Eric HilliardProducer/editor: Eric HilliardAll things habitatCostal plain marshAllegan State Game AreaRoss costal plain marsh preserveAll things feathersSpruce grouseRuffed grouseSharp-tailed grouseAll things furIndiana batWhite-nose syndromeQuestions or comments about the show? Contact the DNR Wildlife Division at 517-284-9453 (WILD) or email dnr-wildlife@michigan.gov.

Send us Fan MailA spring bear bait run can feel routine… until a sow comes in hard and closes the distance to two feet. We're joined by New Brunswick hunter, guide, and podcaster Wesley Thebeau for a wide-ranging talk that moves from traditional archery fundamentals to the real workload behind running a bear outfitting camp, plus the bird dog obsession that takes over every fall.Wesley explains how he got hooked on trad bow hunting, why “trad bow close” is a non-negotiable standard for many hunters, and how he sets baits to deliver true 10 to 15 yard shots. We dig into spring bear hunting strategy, tracking decisions, and why spring can outperform fall when natural food is everywhere. Then we get the backstory on March and Milco and how an unexpected partnership forms with NHL star Brad Marchand, including what it's like to watch a world-class athlete bring that same mindset to archery practice and camp life.From there we shift into upland hunting in New Brunswick, woodcock migration, thick clearcut cover, and what makes the region a legitimate destination for grouse and woodcock hunters. Wesley talks versatile hunting dogs like the Deutsch Drahthaar, why they demand year-round structure, and how fat biking groomed winter trails keeps both dogs and handlers ready. We round it out with wild game cooking, the carnivore diet discussion, and his push to improve the outdoor industry through United Guides and Outfitters of New Brunswick.If you enjoy spring bear hunting, traditional archery, bird dogs, woodcock hunting, and honest outfitting stories, hit subscribe, share this with a hunting buddy, and leave a review with your biggest takeaway.Check us out on Facebook  Hunts On Outfitting, or myself Ken Marr. Reach out and  Tell your hunting buddies about the podcast if you like it, Thanks!

Neurologic care during pregnancy and menopause requires careful attention to the dynamic interplay between hormonal transitions, evolving evidence on diagnostic and treatment safety, and the lifelong risks associated with neurologic complications of pregnancy. In this episode, Katie Grouse, MD, FAAN, speaks with Sara C. LaHue, MD, author of the article "Neurologic Complications of Pregnancy and Menopause" in the Continuum® February 2026 Neurology of Systemic Disease issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California, San Francisco in San Francisco, California. Dr. LaHue is an assistant professor of neurology for the Weill Institute for Neurosciences in the Department of Neurology at the University of California, San Francisco School of Medicine in San Francisco, California Additional Resources Read the article: Neurologic Complications of Pregnancy and Menopause Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Grouse: Despite the high prevalence of neurologic conditions in women, critical gaps remain in training, research, and clinical guidelines on sex and gender specific considerations across the lifespan. Today, I have the opportunity to speak with an expert on neurologic complications of pregnancy and menopause and coauthor of the and women's neurology curriculum core competencies, Dr Sara LaHue about the latest issue of Continuum on neurology of systemic disease. Dr Jones: This is Dr Jones, editor in chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Sara LaHue about her article, Neurologic Complications of Pregnancy and Menopause, which appears in the February 2026 Continuum issue on Neurology of Systemic Disease. Welcome to the podcast and please tell us more about yourself. Dr LaHue: Well, thanks so much for having me. I'm really excited to talk about this topic. So, I'm Sara LaHue. I'm a neurologist at UCSF, assistant professor of neurology, and a neurohospitalist. So much of my role is taking care of people who are coming into the hospital with urgent and emergent neurologic conditions. And so that's very much a framing that I come to this chapter with. Dr Grouse: I just want to start by congratulating you on your article, which is such a phenomenal compendium of important neurologic issues related to pregnancy and menopause, which I think I really needed and a lot of us really need and was missing, I think, in all of the literature out there. This article will be such an important clinical resource. I know for me, and I'm sure for many of our listeners, this may be a difficult question to answer because of how comprehensive the article is. But what do you hope will be the main takeaway for those who read your article? Dr LaHue: So, I really hope that listeners walk away with understanding that pregnancy and menopause are not contraindications to providing excellent neurologic care. I think too often we default to withholding treatment, pseudo-assumed risk, rather than actual evidence of harm. And so, I think that the key message here is that protecting maternal health is protecting fetal health, and that under-treating neurologic conditions during pregnancy can harm both mother and baby. Dr Grouse: You did say specifically in your article that I thought it was so important that presumption of harm from medications during pregnancy, due to lack of evidence rather than evidence of harm, was something that we really had to be aware of, of that bias. And how do you recommend neurologists listening to this podcast approach situations where diagnostic or management strategies become less certain due to safety considerations in pregnancy? Dr LaHue: Yeah, that's such an important question. I really frame it as a risk-benefit calculation with a patient, and I'm very transparent about what we know and what we don't know. And I emphasize that untreated disease may also impact fetal health. I use resources like LactMed and pregnancy registries that can help provide some of the more latest data. And then when evidence is limited, I document our discussion thoroughly, and I'll often involve maternal-fetal medicine colleagues for their multidisciplinary input. So, the goal is really to have an informed, shared decision-making process rather than a reflexive avoidance of all treatments. Dr Grouse: I think that's really important to reiterate, and I think something that we're all I think working on as we try to manage these difficult situations and conditions. Now, I want to switch gears a little bit and ask. Your article was so comprehensive and so helpful, but what isn't in the article that you wanted to put in? Dr LaHue: There was a fair amount that I ended up having to take out. So, this is a question that's near and dear to my heart. So, I would have liked to include more on the neurodevelopmental outcomes for children who are exposed to various neurologic medications in utero. And I also wanted to discuss more about transgender and non-binary individuals who are experiencing pregnancy and menopause, as they're often underrepresented in research. They've faced unique challenges accessing care. Dr Grouse: Now, I was really struck by one statistic in your article, specifically that intimate partner violence is a leading cause of head injury during pregnancy, and that actually homicide is a leading cause of death during pregnancy in the postpartum period in the US, which was absolutely a surprising statistic to me. What does this mean for our listeners caring for pregnant patients with concussions and head injuries? What should we be doing differently? Dr LaHue: This is also something that really struck me when I first encountered it. I think that the statistics should really fundamentally change how we approach head injuries in pregnant patients. I think we need to screen everyone routinely and privately for violence in the home and in the relationships, and to document injuries very carefully. But we also need to be prepared if someone does screen positive. And so, it's important to be familiar with what's available in terms of resources within your community, where you work, and also to remember that that strangulation in particular is something that can cause dissection and stroke. And so, to maintain a high index of suspicion for any kind of vascular injury in these cases. So not just thinking about head injury itself, but also thinking about complications of strangulation as well. Dr Grouse: Really a great reminder of the role that we can play in our own careers and our own clinical settings when we see cases like this. So, I really appreciate that this point was made, and I hope this will change people's practice. Now switching gears to stroke in pregnancy. Could you walk us through your evaluation and management of a patient who comes in with acute stroke in the peripartum period? Dr LaHue: This is such an important topic, and I think the first thing I'd like to emphasize is that time is brain. Whether or not you're pregnant. It's important to get whatever imaging modality is going to be fastest. Get the CT or get the MRI as soon as you can. Don't delay for fetal concerns. The radiation risk is minimal compared to missing a treatable, disabling stroke. In terms of treatment, thrombolysis and mechanical thrombectomy should be considered just as in a non-pregnant person, when the benefits outweigh the risks. And so, I think the key is involving obstetrics early for shared decision making, and being very transparent with what treatment options are available for the individual, and to not let pregnancy alone stop you from offering standard stroke therapies. Dr Grouse: Definitely a helpful resource, and I think the resources that you put in specifically around the considerations and differentials in these various populations. Postpartum, while still pregnant during the period of period, I think is all just so helpful and a great review. So, I encourage our listeners to check that out. Now switching over to the topic of menopause. I have to say, I really appreciated your coverage of neurologic issues related to the perimenopause period. What do you think is the biggest debate or controversy in this area? Dr LaHue: I think this has to be our understanding of the use of menopausal hormone therapy. The pendulum, when using menopausal hormone therapy, has really swung dramatically. So, we went from routine use to predominantly avoidance. After the Women's Health Initiative was published in 2002, and now we're finding that we're starting to come more to a middle ground. I think there's still great debate when it comes around timing of initiation, formulation of the different therapies, a route of administration and also the dosing, as well as just including how to individualize therapy for individuals with neurologic conditions. Dr Grouse: Well, going into that a little further, I know I get a lot of questions about the use of hormone therapy as it relates to stroke risk and particularly in higher risk patients such as patients who've had prior strokes, dissections, a history of migraine with aura. And I find it hard to get the answers in the literature that's out there. How are you counseling these patients? Dr LaHue: So, I think this is where discussions around the route of administration and dosing become especially important. And this is where there's emerging literature that I think is helping to guide some of these discussions. So, for higher risk patients, I discuss how low dose transdermal formulations which can bypass hepatic metabolism and reduce clotting risk. These are medications that can appear safer in those higher risk individuals. I think the key is really individualizing the risk-benefit discussion with the patient. For a woman with severe vasomotor symptoms that are affecting sleep and cognition, who had a remote stroke. I think this is a person for whom low dose transdermal patch might be a reasonable option. All of these factors end up being considerations for that shared decision-making. Dr Grouse: Now your article covers another topic that I often get questions about, and that's specifically regarding safety of vaginal delivery for patients with neurologic conditions that are sensitive to increased intracranial pressure. Could you summarize your advice for these types of questions when they come up? Dr LaHue: So broadly speaking, most neurologic conditions don't require C-section delivery. And this is a procedure that, just globally speaking, as has been increasing dramatically. And so, I think that's the key message that really, most neurologic conditions don't require a C-section as a main indication. And really, the indication should be based on obstetric considerations. For most conditions, like controlled idiopathic intracranial hypertension, a vaginal delivery is fine. But for patients with mass effect or obstruction at the foramen magnum, a C-section with general anesthesia, it's probably going to be safer. The transient increase in intracerebral pressure that can come with pushing. It hasn't really been shown to harm patients who have stable, treated neurologic conditions. Dr Grouse: I really appreciated the advice that you given in the article, which was that if generally you feel like this would be a patient who would be safe to get a lumbar puncture, you have a little less concern about vaginal delivery versus those that you feel would not be safe to get a lumbar puncture, that you'd be more leaning towards a C-section. Dr LaHue: Yeah, that's exactly right. Dr Grouse: Now, why do you think we have so many gaps in our understanding of how pregnancy and menopause affect neurologic conditions? Dr LaHue: So, I think it really comes down to a perfect storm of factors. So, in 1977, the USFDA came down with the recommendation, stating that it was best to exclude all women of reproductive potential from both phase one and phase two studies. And this recommendation wasn't reversed until 1993. And there are also concerns around liability and also the fact that pregnancy is a temporary state is something that may falsely minimize the potential for delays. The potential for harms that come with delays in treatment. And I think that the fact of menopause is also historically been dismissed, despite this is something that is affecting half of the population. I think we need systemic change. We need to mandate inclusion in research. We need funding for dedicated studies. We also need to recognize women's health as a core competency and not just a special interest. Dr Grouse: That all sounds like a great roadmap for improving our knowledge. And I really hope we get there. But hearing you talk about it really does give me hope that we can improve how we are understanding and treating these conditions. Now, your article included a really helpful overview of headaches in pregnancy, and that's certainly something I think many of our listeners are very familiar with. We do have a lot of questions around that, and I think there's a lot of areas where we don't really always know what the best thing to do is. I think that your article really gave a lot of great information and a really great framework to think about. It would be wonderful to hear you walk through your approach to evaluation of a patient who was pregnant with a new onset headache. Dr LaHue: You'll see in this chapter that I introduce a mnemonic that's spelled out pericardium as a framework for thinking about headache and pregnancy. And here are the you specifically points to an unusual headache, referring to a new or atypical presentation of headache for the patient. I think this is an important place to start, because one of the initial considerations should be this is a new headache, or is this an old headache? If this is a patient who already has a preexisting diagnosis of migraine or some other primary headache disorder, then it's certainly possible that the headache that they're experiencing during pregnancy is also a continuation of their primary headache disorder. But certainly, our role is to make sure that we're not missing a scary complication, a secondary headache that could be dangerous to the patient. And so, then this is where I also think about, well, where are they in the course of their pregnancy. Is this person currently pregnant or are we in the postpartum period? When someone is after 20 weeks gestation, one of the first things to consider is going to be preeclampsia. And so, it's important in those individuals to check blood pressure, check urine to rule out preeclampsia, as this is always going to be top of mind after 20 weeks. I think it's also important to emphasize that preeclampsia is not just a condition that can occur when someone is pregnant. This is also something that can occur postpartum. One needs to be vigilant for looking out for this complication during both time periods. And then I think for new headaches, I really want to focus on what the timing is and any other red flags. For example, if it's a thunderclap headache and onset, then I might be worried about something like RCBS or cerebral venous sinus thrombosis. If the headache itself is orthostatic and patient may have had an epidural, then I might think about a post-dural puncture headache, which is a, unfortunately very common complication and reason for headache in the postpartum period. I think the key is that most dangerous headaches often will occur late in the third trimester or early postpartum. And I think it's also important to remember that if you need imaging to make the diagnosis, and you should get it. The risks of missing something serious far outweigh concerns that one might have around imaging. And when possible, it's certainly preferred to get an MRI if that's available. Dr Grouse: I really did appreciate articles, overview of the various imaging modalities out there and the overview of risk versus benefits and times where they may or may not be needed. So, yet another very useful piece of information that I think that our listeners will appreciate in your article. Now, I'm curious how did you get interested in this area of neurology? Dr LaHue: So, it really was my interest in both reproductive health and neurology that led me to go to medical school in the first place. I knew early on at the beginning of medical school that I was interested in neurology, but I also was very drawn to obstetrics, and I recognized in medical school and then further on as, as a resident, just how vast the knowledge gaps were. When I was counseling my own patients and I found this to be just a very frequent source of frustration as both a clinician and a researcher, I very much feel an obligation to try to help fill these gaps. And I've also just been very encouraged by an outstanding community of other neurologists that I've been able to meet in this space. It's been a just a wonderful collaborative network that we've been able to grow, both within United States and even more globally, when it comes to other neurologists who are interested in this topic. And I'm just very excited to see the direction that this field is going in. Dr Grouse: Well, we can't wait to learn more as this field develops and more is understood about the right way to approach these types of diagnostics and treatments. So, thank you for all your work in this space. And it's been absolutely fascinating reading your article and talking with you today. Dr LaHue: Well, thank you so much for having me, and I'm just so thrilled that these important topics are going to be part of this issue of Continuum. Dr Grouse: Again, today, I've been interviewing Dr Sara LaHue about her article and Neurologic Complications of Pregnancy and Menopause, which appears in the February 2026 Continuum issue on Neurology of systemic disease. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, associate editor of Continuum Audio. If you've enjoyed this episode, you'll love the Journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe AA and members. You can get to me for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this podcast, Jon Teater (Whitetail Landscapes) and Cody Altizer (Give for Grouse) delve into the intricate relationships within ecosystems, emphasizing the importance of habitat types, specialist species, and the interconnectedness of forest life. It highlights the significance of historical context in understanding current conservation efforts and the role of native shrubs and food sources in supporting wildlife. The discussion also touches on sustainable practices for wildlife management and the ongoing research efforts aimed at preserving biodiversity. Takeaways Continuous learning is essential for personal and professional growth. Understanding habitat types is crucial for effective conservation. Specialist species play a vital role in maintaining ecosystem balance. Ants are integral to forest ecosystems and their health. Historical knowledge informs current conservation practices. Native shrubs provide essential food sources for wildlife. Sustainable practices are necessary for ecosystem health. Research efforts are critical for wildlife conservation. Interconnectedness of species highlights the complexity of ecosystems. Effective habitat management requires a holistic approach.   Social Links https://whitetaillandscapes.com/ https://www.facebook.com/whitetaillandscapes/ https://www.instagram.com/whitetail_landscapes/?hl=en https://www.facebook.com/GiveforGrouse/ https://www.youtube.com/@GiveforGrouse https://podcasts.apple.com/us/podcast/give-for-grouse-podcast/id1856599149 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fire is one of the most powerful tools in habitat management—but most landowners never use it. Habitat manager Erich Long returns to break down prescribed fire, timber stand improvement, invasive species control, and how burning and logging work together to restore wildlife habitat for the deer we want to hold this fall. If you're serious about improving land and managing better habitat, this conversation is worth your time. Sit back, relax, and enjoy the show. 00:00 Introduction09:07 Why Fire Matters for Wildlife23:58 The Reality of Controlled Burns30:11 Why You Need a Qualified Burn Manager40:40 Balancing Fire and Wildlife49:01 Burn Safety and Smoke Management57:37 Managing Warm Season Grasses01:01:07 Timber Management for Wildlife01:10:41 The Economics of Logging and Habitat01:29:52 The Frustrations of Deer Management01:49:51 The Pressure of Modern Hunting02:05:49 Rediscovering the Joy of HuntingCheck out Give for Grouse:https://www.facebook.com/GiveforGrouse/https://www.youtube.com/@UCfjOVyRF0b1OKPnL7yzkUNw https://www.instagram.com/give_for_grouse/SUBSCRIBE TO THE CHANNEL:https://www.youtube.com/c/HUNTRTUBEShop HUNTR Merch:https://wearehuntr.com/HUNTR Podcast is presented by:Hoyt Archery: https://hoyt.com (Code HUNTR for 20% off apparel)DeerGro: https://www.deergro.com (Code HUNTR for 15% off)Predator Camo: https://www.predatorcamo.com/ (Code HUNTR for 20% off)Beast Broadheads: https://beastbroadheads.com/ (Code HUNTR for 10% off)Lone Wolf Custom Gear: https://www.lonewolfcustomgear.com/ (Code HUNTR for 10% off)RackHub: https://www.rack-hub.com/huntr (Code HUNTR for 10% off)Pure Wildlife Blends: https://www.purewildlifeblends.com (Code HUNTR for 10% off)Primos: https://www.primos.com/ (Code HUNTR for 15% off)Bushnell: https://www.bushnell.com/ (Code HUNTR for 15% off)HHA: https://www.hhasports.com/

I can remember when a day hunting in the woods almost guaranteed you'd flush a few grouse. Today, things look very different. Grouse numbers have declined across much of their range, and in many places the opportunity to hunt them has disappeared altogether. In this episode, we're joined by Cody Altizer and Erich Long from the “Give for Grouse Initiative”. They're working to raise awareness and support for habitat restoration and conservation efforts aimed at bringing grouse populations back where they belong.We talk about what's happened to the grouse population in Ohio and across other states—and why the decline isn't caused by just one issue. Cody and Erich also share what landowners can do to improve habitat on their property, and how everyday sportsmen and women can make a difference.If you care about wildlife, forests, and the future of upland hunting, this podcast is for you.

Joining Marc this week is Bill Koepke and they talk about Grouse hunting from last year, Hunting dogs, Knowles Nelson Stewerdship Fund and the importance of it, Greater Praire Chickens in Central Wisconsin and The Praire Chicken Festival April 11th for more info: https://www.wisprairiechickens.org/home

Joining Marc this week is author Jon Steffes,  They talk about waterfowl hunting on the Mississippi River, teaching 4th graders and their experiences in the outdoors, The Armistice Day blizzard, Grouse hunting, How he became an author and more.

Grouse_for_Dinner

Grouse for dinner

It's a Would You Rather Wednesday and we've got some scenarios about your relationship and whether or not you'd tell on a colleague that's breaking the rules at work. Plus: What's a show you had to give a few episodes too before it got good? Nat is now all-in on the new Game of Thrones spin-off after disliking the first two episodes Drew was in Vegas for his son's football tournament - his first overnight trip to the US in over a year. What was Vegas like after hearing all the stories about the decline in tourism? Grouse Mountain is celebrating 100 years - what are some of your favourite memories of Grouse?

"Grouseman" Steve Grossman is joined by his son Travis as we get a pro-guide two-fer. These guys know ruffies, sharpies, Huns and prairie chickens from decades guiding in both South Dakota and Minnesota. We'll cover habitat and habits, less-common food sources and their importance, and what really matters on a hunt. Both talk dog handling, broaden our definition of "edge cover," discuss pairing cockers with pointing breeds, and share lore and legend from the grouse woods and vast prairies. "Fix It" is a primer on e-collar considerations for young dogs, and listeners answer the question "Do you trial or test, and why?" And it's all brought to you by: HiVizSights.com, Mid Valley Clays and Shooting School, CableGangz, TrulockChokes, Pointer shotguns, Purina Pro Plan Sport and FindBirdHuntingSpots.com.

In this heartwarming episode of The Birdshot Podcast, Host Nick Larson welcomes back Tim Flanigan, a revered outdoorsman, author, photographer, and retired game warden. Now in his 80s, Tim reflects on a life immersed in upland bird hunting, wildlife photography, and conservation. He shares rich stories from his time in the field, thoughts on aging gracefully, and timeless lessons passed down through generations of hunters and mentors. Tim Flanigan is a celebrated upland bird hunter, retired game warden, and author of books such as Grouse & Woodcock: The Birds of My Life and the Night Killers series. Known for his evocative writing, wildlife photography, and depth of field knowledge, Tim has become a treasured voice in the hunting community.  Expect to Learn:  Why life truly begins at 40, especially for outdoorsmen The value of mentorship and passing on hunting traditions Tales from the field: from poachers to unforgettable first grouse hunts Insights into Tim's books, including Grouse & Woodcock and Turkey Man How aging changes a hunter's priorities from the kill to the memories Episode Breakdown with Timestamps: [00:00:00] - Welcome & Turning 80 with Tim Flanigan [00:02:56] - Life Begins at 40 [00:05:30] - What inspired you to write an article? [00:14:43] - Chasing Grouse and Outlaws: A Game Warden's Story [00:19:43] - Grouse, Woodcock, and the Joy of Observation [00:41:58] - What do you look at when you're shooting? [00:53:09] - The grouse's morning stretching routine [01:12:39] - Photo Tim wants to capture [01:28:17] - Book Recommendations and Final Thoughts Follow The Guest, Tim Flanigan Facebook: https://www.facebook.com/TimFlanigan.NatureExposure/  Instagram: https://www.instagram.com/timflanigan418/?hl=en  Book#1:https://www.wildriverpress.com/product/grouse-woodcock-timothy-c-flanigan-wild-river-press/ Book#2:Poacher Pursuit: Game Warden vs Wildlife Killers Book #3:Night Killers: Blood Lusting Poachers Follow the Host Nick: Instagram: @birdshot.podcast Website: www.birdshotpodcast.com Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshot.podcast SUPPORT | http://www.patreon.com/birdshotUse Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this article, David Frey writes about how catastrophic wildfire and increasingly warm, dry climates may eliminate dusky grouse in the southern Rockies by 2060.Use code UPLAND15 to get 15% off at yonderbound.co.Read more at projectupland.com.

I first met Ben at my place in Virginia. We shared a drink, a bunch of stories and stayed in touch over many years. Ben and a few friends have figured out that Virginia is a true mixed bag of opportunities for anyone wanting to chase upland birds. As long as you don't mind going up hill both ways. This episode brings me back to the reason love this lifestyle. 

Populations of the Greater Sage Grouse have dropped by 80 percent over the last 60 years. That’s because the iconic bird depends on high desert sagebrush for food and habitat. And that habitat has been threatened for decades by wildfire, human activity and invasive species. A historic agreement that came together in 2015 to protect these birds and keep them off the endangered species list has helped turn that trend around. But now, a potential lithium mine could blow up the whole deal.  OPB “Oregon Field Guide” producer Cassandra Profita fills us in on the details and you can see the video and article she recently produced about sage grouse here. We also hear from journalist Ashley Ahearn, who created an 8-episode podcast series called “Grouse” all about the birds and what they can teach us about compromise and life in rural America. Don’t forget to check out our many podcasts, which can be found on any of your favorite podcast apps: Hush Timber Wars Season 2: Salmon Wars Politics Now Think Out Loud And many more! Check out our full show list here.

Tim Linehan of Linehan Outfitting is an Orvis-endorsed guide hunting the Rockies for ruffed, sooty and blue grouse. It's challenging country, different habitat, offering a new set of rules he's here to explain. Whether you're a dyed-in-the-wool ruffed grouse hunter or new to the game, from the east, midwest or west, there's something in his approach of value to you and your dog. We cover what is good habitat and finding it, how to approach a covert, why a bell and beeper might be the ultimate combination. Tim shares his shooting advice ("shoot the shadow") and how to approach a bird and dog on point, we'll also learn more about what western grouse are eating.  "Fix It" has another way to remove cockleburrs, and listeners share their bad hunting buddy horror stories. And it's all brought to you by: HiVizSights.com, RuffLand Kennels, Mid Valley Clays and Shooting School, TrulockChokes, HiViz shooting systems, Pointer shotguns, Purina Pro Plan Sport and FindBirdHuntingSpots.com.

Let's start 2026 by chatting about games we played over the break, including Miles Morales, Civ 7, Absolum, and Vinny's... feelings about Metroid Prime 4. We also round up the the news over the holiday, like the tragic passing of Vince Zampella, next-gen consoles maybe getting delayed, possible new DLC for The Witcher 3, changes in GOG's ownership, and more.CHAPTERS(00:00:00) NOTE: Some timecodes may be inaccurate for versions other than the ad-free Patreon version due to dynamic ad insertions. Please use caution if skipping around to avoid spoilers. Thanks for listening.(00:00:10) Intro(00:03:00) 2026 and the business of video games(00:06:10) Some purchases during our break(00:13:38) Professor Layton still rules(00:18:15) What the heck are the kids reading these days?(00:19:18) No more generations, except Generation Remix(00:21:47) Metroid Prime 4: Beyond  |  [Nintendo Switch, Nintendo Switch 2]  |  Dec 04, 2025(00:32:52) First Break(00:35:13) More of the games we played during break(00:35:46) Marvel's Spider-Man: Miles Morales  |  [PlayStation 4, PlayStation 5]  |  Nov 12, 2020(00:42:12) Death Stranding 2: On The Beach  |  [PlayStation 5]  |  Jun 26, 2025(00:45:43) Sid Meier's Civilization VII  |  [Mac, PC (Microsoft Windows), Linux, PlayStation 5, PlayStation 4, Xbox Series X|S, Xbox One, Nintendo Switch]  |  Feb 11, 2025(00:51:51) Absolum  |  [Nintendo Switch, PC (Microsoft Windows), PlayStation 4, PlayStation 5]  |  Oct 09, 2025(00:58:35) Second Break(00:58:40) Vince Zampella's death(01:05:55) RAM prices and next gen planning(01:13:56) The Witcher 3 is getting more DLC?(01:16:52) GOG is being sold... sort of?(01:19:52) Yoji Shinkawa designs some real gear!(01:27:02) Alex has some breaking news(01:28:55) Emails(01:40:32) Wrapping up and thanks(01:44:07) Mysterious Benefactor Shoutouts(01:46:32) See ya!

Dementia is often a highly burdensome disease process for patients, their caregivers and families, and the community at large. Palliating symptoms and providing guidance surrounding advance care planning and prognostication are integral components of the management plan. In this episode, Katie Grouse, MD, FAAN, speaks with Neal Weisbrod, MD, an author of the article "Neuropalliative Care in Dementia" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Weisbrod is a neurologist at Hartford Healthcare with the Ayer Neuroscience Institute in Mystic, Conneticut. Additional Resources Read the article: Neuropalliative Care in Dementia Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Neal Weisbrod about his article on neuropalliative care in dementia, which appears in the December 2025 Continuum issue on neuropalliative care. Welcome to the podcast, and please introduce yourself to our audience.  Dr Weisbrod: Thank you. I'm really excited to be here. I'm Neal Weisbrod. I'm a neurologist and palliative care physician currently working at Hartford Healthcare in Mystic, Connecticut. Dr Grouse: To start, I'd like to ask why you think it's important that neurologists read your article? Dr Weisbrod: The primary reason I think it's really important to read the article is because these are just really common problems that neurologists run into in clinical practice. So, Alzheimer disease and many other dementias are extremely common, and managing the burdensome symptoms and the complex discussions that we have to have with the patients and their families as they go through the course of dementia is something that is very common in clinical practice. And so my hope is that by reading this article, clinicians will pick up a few tools, a few new ideas for how to make these conversations easier and for how to help these patients get through the disease with a little bit less suffering. Dr Grouse: I learned a lot from reading your article, and I really encourage our listeners to check it out. But I was curious what you feel that you discussing your article would come as the biggest surprise to our listeners? Dr Weisbrod: So, I think that the most surprising thing a lot of people will see reading this article is the section on prognosis. A lot of times it seems families are counseled, when they're talking about the prognosis of Alzheimer disease, that it could be ten years or longer. But really, the data show that for many patients, the median prognosis is closer to three to eight years. And that is a little bit longer for Alzheimer disease than many other types of dementia, but also gets significantly shorter as patients get older. So, we're looking at a closer to three-year median prognosis for patients who are over eighty-five, whereas patients in their sixties are probably closer to the eight or nine-year median prognosis. And so I think that piece will hopefully help people give a little bit more accurate counseling about prognosis.  Dr Grouse: I'm glad you brought that up because I was wondering, why is it so important that we are careful to make sure that we're giving prognostic information for our patients and maybe even updating it as their clinical status changes? Dr Weisbrod: I think first of all, it's a really common thing that patients and families are thinking about and worried about. They don't necessarily always seem to ask as much as they want to know. I think there's a lot of fear around that conversation, even though it's really important. And then there's also often tension between the family and caregivers tend to want to know more than patients do. I think that it really helps people plan for the future as well as possible to know what their future might be. And we have a lot of limitations in predicting the future, but using the best information we can, laying out what we think the likely range is, allows people to make a lot more clear plans for their future. Dr Grouse: I'd imagine it's also pretty helpful for hospice referrals, too, having that data.  Dr Weisbrod: Yeah, definitely. And there's a lot of angst about when to refer patients who have dementia to hospice. The most important thing I think about when I'm making a hospice referral is that I don't have to be right. And I think it takes a lot of that concern off to just say, all I'm doing is making a connection, getting someone who's potentially interested in the hospice, who has a really advanced serious illness connected to a hospice agency. And then they can go through the full evaluation with the hospice and the hospice medical director and determine whether they're eligible. So, I think there are really helpful thresholds to think about that would be a good trigger. Like a patient who we think has advanced dementia, who has a hospitalization for pneumonia or a fracture of the hip or some other really serious acute medical condition, I think is a really good trigger to start to think about hospice. But most importantly, it's just the connection, and I tell the patients that upfront. I tell them that you're going to have a conversation and we'll decide whether you're a good fit, and if not, the hospice will usually just check in with you over time and decide when is the right time in the future. Dr Grouse: That's really helpful. And I think just a really great reminder to our listeners about thinking about hospice sooner or at certain critical points in their patient care rather than waiting, maybe, before it's gone on too long and may be of less use later on. I was wondering, in your own clinical practice, what do you think is the most challenging aspect of providing care to patients with dementia?  Dr Weisbrod: I think this one's easy. I would say managing the time has to be the most difficult part. I think that taking care of patients who have dementia is time-consuming. There's a lot of different priorities that we have to manage the time around. How much time are we going to spend doing cognitive testing? How much time are we going to spend doing counseling? How much time are we going to spend making up a treatment plan and discussing medications? How much time are we going to spend on advanced care planning? And the way I try to combat that is really just trying to think about what I'm going to prioritize in a certain visit and not try to accomplish everything. I'll tell patients and their families, the next time you come in, we're going to have a conversation focusing on advanced care planning. Or, the next time you come in, we're going to sit down and try to talk through all the questions you have about what the future might hold. That way I in that visit, I don't feel like, oh, I have to do updated cognitive testing and I have to review all the next steps in medication, and that allows me to take it in more bite-sized chunks. Dr Grouse: You made some of the great points, and specifically you mentioned advanced care planning. Your article makes a really strong case for the importance of advanced care planning, yet you definitely acknowledge the many barriers to initiating discussions that clinicians face. In your patients with dementia, can you walk us through how you integrate discussions about advanced care planning with your patients and their families?  Dr Weisbrod: Yeah, I think this is still something that is evolving in my practice, and I don't think there's any perfect way of doing it. I think there's a lot of right ways of doing it, and as long as we're thinking about it a lot and bringing it up periodically, that's probably the best. What I try to do, though, is after I discuss what I think is the most likely diagnosis with patients and their families, I try to have a fairly close follow-up visit after that. Allow them to digest that information, to often do a little bit of their own research, to talk about it as a family. And then when they come in for that next appointment, I try to at least lay some groundwork about advanced care planning, asking them what they've completed already, and then based on what they've already done to that point, talking to them about what I think the next step would be. If they have done nothing, usually it's just, hey, I really think you should start to think about who would be making decisions for you if you lose the ability to make your own decisions and counsel them about power of attorney paperwork and establishing a healthcare surrogate. When it's patients who have already done some of that initial prep, I think that it's really important to keep in mind it's a longitudinal discussion and you can take it in small pieces over time. Often that helps because you can really establish that rapport and that trust. And then I like to just keep checking in whenever there's major changes in the patient's health or condition, like admission to the hospital or transfer to an assisted living facility or memory care clinic. Those are good times to remember, hey, I really need to revisit this conversation.  Dr Grouse: It's probably good to also mention another really important point from your article, which was that impairment of decision-making in patients with dementia can actually start significantly even in the phase of mild cognitive impairment. Yet these patients will need to make many medical decisions with their neurologist as they go through this journey. How can we make sure our patients have capacity and make decisions appropriately regarding their care? Dr Weisbrod: Yeah, I think that's a definite challenge of taking care of patients with cognitive disorders of any type, including those with stroke and multiple sclerosis, that have some cognitive impairment. In my opinion, the most important way to help manage that is to make sure when we are making important decisions about the future that we're having a deep exploration of the values and the reasoning behind that. And definitely teach back is the most helpful way that I use to explore those values and the logic behind patients' decisions. So, I think we have to have a really low threshold to move on to a formal evaluation of capacity; if there's any inconsistency between what the patient's saying now and what their families say they've said in the past, or if they're having struggled to come up with a really clear logic behind their decision, then I think we have to have a low threshold to move on to a formal evaluation of capacity. So, I think having the family involved, having other people who know the patient really well, usually helps identify some of those periods where it seems like the patient's not making the decision that really reflects their true wishes. Dr Grouse: Now I wanted to switch gears a little bit and get into the management of neuropsychiatric symptoms, which you spend a lot of time on and I think a lot of neurologists find very challenging. What are some nonpharmacologic approaches that can help patients with significant neuropsychiatric symptoms?  Dr Weisbrod: I really like the DICE paradigm for coming up with nonpharmacologic approaches. The DICE paradigm is an acronym. The D is Describe, I is Investigate, C is Create, and E is Evaluate. The idea is that we're exploring what's happening behind the symptoms, we're creating a plan to intervene, and then we're evaluating the outcome of that plan and creating a sort of feedback loop there. But ultimately, I think, when we're creating a solution, thinking about how we can change the environment is the most important thing. We have very limited ability to change the way that someone who has severe cognitive dysfunction reacts to their environment, but we can often change the environment to not produce that reaction in the first place. One example is with wandering behaviors. Trying to change the environment where you put locks that don't have deadbolts that you can use on the inside of the house, you have to have a key on the inside of the house, and then the family can put that key somewhere safe where the patient is not likely to find it and be able to unlock the door and wander out unsafely. I also think it's really important to acknowledge that as doctors, we are maybe not the best people to always have the answer when it comes to changing a patient's environment. And so, I think we really need to rely on the wisdom of support groups and other people who are going through the challenge of dementia. Our interdisciplinary care teams like social workers and nurses who have experience in managing dementia, and really try to plug the caregivers into as many of these avenues as possible so that they can learn from all of that community of wealth and not always rely on the doctor to have the answer. Dr Grouse: Switching gears to pharmacologic management, which is a lot of what we do for patients as neurologists. Thinking about agitation, pharmacologic management of agitation can be very challenging. And reading your article, it reminds me how disheartening it is to reflect and how modest the effect of the available options are, along with the many potential risks of their use, When nonpharmacologic interventions fail, what should neurologists recommend for their patients with agitation? Dr Weisbrod: Yeah, I definitely agree. It's every time I go back and look at this literature and look at what's new, it is a bit disheartening. But even in the face of all that, I really feel like SSRIs are my first-line therapy for most of these patients. I always try to ask myself what might be causing the patient discomfort that they are then manifesting as agitation because they don't have a better way of expressing themselves. Often, I feel like that's anxiety or depression or some other psychological symptom that we might be able to address with an SSRI. So, I tend to use sertraline and escitalopram, start those early and as long as patients are tolerating it, give it a really good trial. Outside of that, escalating to other pharmacologic approaches, even though there's such controversy in the data about antipsychotics and even though there are very real risks, sometimes I think we essentially do need a chemical sedative. And I think that it's important to have a very frank conversation upfront with the caregivers and the medical decision maker for that patient. Make sure we are counseling them on the risk, the increased risk of mortality, and also to make it a time-limited trial. So, I think that saying we're going to try this medication (if the patient's decision maker agrees, obviously) for a month or two months or three months. But I definitely wouldn't want them to just have an open-ended plan where they're going to stay on it indefinitely. It should have some end point where we say, hey, is this working or not? And if it's working, then we'd make a decision, is the improvement in quality of life worth the risks? And if we're not seeing that improvement, then we definitely need to stop it. Dr Grouse: That seems very reasonable. And then thinking more towards some of the other types of symptoms that can be really challenging, I was really surprised to see how often uncontrolled pain is a significant contributor in patients with dementia. And certainly, both uncontrolled pain and poor sleep can worsen cognitive function and neuropsychiatric symptoms in general. But of course, there's ongoing concerns about side effects of these therapies and how they can also potentially worsen things. How should we be approaching management of pain and insomnia or poor sleep in these patients?  Dr Weisbrod: I think the key is just to start with really low burden treatments and escalate carefully and start with low doses of higher risk medications. So, when I think the low burden treatments for pain, scheduling acetaminophen, 1000 milligrams every eight hours, seems like a trivial thing to do, maybe? But it's actually surprising how much scheduled acetaminophen can take the edge off of pain and might be able to avoid some of these flare-ups of neuropsychiatric symptoms, may be able to really improve that pain a little bit. I do think it really has to be scheduled, though. Trying to rely on patients who have significant cognitive dysfunction to use a PRN medication is going to lead to a lot of problems and undertreatment. And then on the sleep disorder side, I think starting with low-dose Trazodone and gradually increasing the dose of Trazodone as a really safe way of initially approaching the insomnia. And then only when it's a more refractory case do I reach for the high-risk medications. Like for pain, we're talking about opiates. I think there's a lot of very reasonable concern about using opioids in patients who have cognitive dysfunction. But if there is a really good reason to think that they have severe pain, like they have a past pain disorder, I think that just like with antipsychotics, there are definitely real risks to these medications. But at the end of the day, if we are improving someone's quality of life dramatically and the patient's medical decision maker is willing to take on those risks, then we're really doing the patients a favor. Dr Grouse: Now, another issue that you mentioned in your article, which I see a lot and often struggle with myself, is how and when to deprescribe certain types of medications such as cholinesterase inhibitors and memantine. Any tips or tricks to how to approach this?  Dr Weisbrod: My approach to this has also evolved a bit over the years. The new data that cholinesterase inhibitors may have a mortality benefit in patients with Alzheimer disease has changed my thinking a little bit. But there are still lots of situations where it's just too burdensome or patients seem to be having side effects. And so, I think about deprescribing. The most important thing in my mind is really thorough counseling before deprescribing with the patient's family and medical decision maker. I think that letting them know that we might actually be holding things more stable with the medication than we realize, there could be a flare-up, that we can resume the medication if that flare-up happens but we don't always guarantee getting back to the same point. I think having that conversation ahead of time will ward off some of the worst issues that you have afterwards. And then I think doing a taper of cholinesterase inhibitors over two weeks to a month is probably the most prudent because of some of the data about withdrawal and exacerbation of neuropsychiatric symptoms or cognitive worsening. Memantine, I think the data is a lot more shaky on withdrawal. And so, I think it's less important to gradually taper memantine. But I think that once again, just having the conversation upfront and letting the family know these are the things we have to look out for and these are the risks is going to be the most important. Dr Grouse: That's really helpful and a great strategy to take advantage of. Another, I think, really difficult topic that I wanted to ask you about was the discussion around nutrition and whether or not to consider putting in some type of a permanent tube for tube feeds. How do you approach that conversation? Certainly a difficult one.  Dr Weisbrod: Yeah, I think it's easily one of the most difficult conversations to have in the care of patients who have dementia. And there's so much emotion in the families when they're having this discussion. And I think really acknowledging there's a huge emotional piece of the conversation is one key piece. For families and caregivers, they're thinking, I don't want my loved one to starve to death. That's usually the most important thing in their mind. We have to address that concern in the conversation, or they're never going to get to a point of satisfaction with the decision that's being made. So, I think while there is still some controversy in the literature about artificial nutrition for patients who have dementia, the bulk of data indicates that it is not helpful for patients. It may exacerbate dementia, it leads to more restraint. And so, I think unless there's some reversible medical condition that we're just trying to do artificial nutrition to get them through, like, they have a stroke and we're expecting that their dysphasia is going to improve because of the stroke is going to heal. Those situations might be a good reason, but if we really think that the driving factor behind their dysphasia is their dementia, I think we should be guiding the families away from that. And I think that explaining that as dementia gets really advanced, the body is slowly shutting down. The body is not needing as much nutrition, and forcing more nutrition in has not been shown to help people who have dementia. Really putting it in that sort of language is going to help the families understand and be comfortable with that decision. I also think that it's really helpful to consider talking to families about what they can do and not have the entire conversation be about what we're not doing or not putting in a feeding tube for artificial nutrition. So, I think really good counseling about, we can do comfort feeding, we can expand what food we're giving the person who has dementia and really focus on foods that they really enjoy and not worry so much about the health and nutrition anymore. I think that focus on what they can take control of can also help make the decision easier for families.  Dr Grouse: I really like that approach. And I agree, it does seem that it being such an emotional decision with just so much a concern about this underlying feeling of not caring for their family member. I think that is a really great way to look at it  and to kind of start off that conversation. Now, I'd love to hear more about what drew you to this field when you first got into your career as a neurologist. Dr Weisbrod: I had an interesting journey to doing neuropalliative care. Definitely didn't know that's what I was going to do when I started neurology residency. At University of Rochester, we had amazing palliative care physicians that were involved in medical school, and so I got a little bit of exposure to it early on. Then when I was in neurology residency, I first of all realized that I really enjoyed making sure that what we were doing respected a patient's wishes. And so, as other people seemed to run away from those conversations, I was really drawn to them. And so that definitely made me realize that that might be more of the right field for me. But also, as I went through neurology residency, I really discovered that I love so many different things in neurology, and that made me not want to subspecialize and focus on a narrower set of conditions in neurology. So, doing palliative care fellowship was a really good way of getting a specialist tool set and expanding my knowledge in one area, but staying a neurologist, generalist. And I think it also really enhances a lot of the other things I do in neurology. It gives me a lot of additional skills on how to counsel patients and how to prepare for the future in general. I think there's a lot about just good bedside manner in palliative care education. I feel like it helped me become a better neurologist, and I decided that I really loved the palliative care piece as well.  Dr Grouse: Well, we're certainly all grateful that you found this aspect of your career and have been able to share the skills you've honed with us as well. And we really appreciate you taking the time to talk with us about your excellent article today, which I encourage everybody to read.  Dr Weisbrod: Yeah, thank you. It's been wonderful to be on, and I hope that people can take away a few small points from the article. Dr Grouse: Again, today I've been interviewing Dr Neal Weisbrod about his article on neuropalliative care in dementia, which appears in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

In this episode of the Birdshot Podcast, Nick Larson is joined by Fritz Heller, a dedicated upland hunter, to discuss the 2025 hunting season, dogs, grouse hunting, and much more. Fritz shares insights into the challenges of the season, including heat waves and the impact on bird numbers, as well as his experience training new puppies. The conversation also gets into Fritz's plans for the future, including his search for a camper for hunting trips and his thoughts on managing bird populations and hunting conditions. Fritz Heller is an upland bird hunter, dog trainer, and dedicated outdoorsman from Michigan. He has been actively involved in training dogs and hunting for many years, sharing his knowledge of the sport with others. Fritz is passionate about the welfare of wildlife, managing habitats, and improving bird populations, and has a wealth of experience hunting grouse, pheasants, and other upland species. Expect to Learn The impact of weather conditions on the 2025 hunting season Heat waves and their effects on bird numbers, especially in the early season The importance of habitat regeneration and the role of different species, like blackberries, in grouse hunting How puppy training can vary by breed, and how Fritz is raising his new Labrador and Cocker Spaniel puppies Fritz's thoughts on taxidermy and the importance of commemorating hunting memories The search for a camper and how Fritz is researching the best setup for his future hunting tripsEpisode Breakdown with Timestamps: [00:00:00] - Introduction [00:10:57] - 37 Degrees and Snow depth [00:19:57] - Fritz's Week Trip this Year [00:36:13] - Different Color Phase [00:43:23] - Discussing the puppy's first season [00:51:37] - Pippa: A Hunting Dog and the difference from a Lab [01:01:40] - Puppy walks [01:13:04] - Ruffed Grouse Drumming in Spring [01:17:28] - Camper, Truck and Rig [01:20:52] - Closing and upcoming plans for the next hunting season Follow the guest, Fritz: How to Hunt Ruffed Grouse with a Flushing Dog: https://projectupland.com/grouse-species/ruffed-grouse/how-to-hunt-ruffed-grouse-with-a-flushing-dog/   Follow the Host Nick: Instagram: @birdshot.podcast Website: www.birdshotpodcast.com Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshot.podcast SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Habitat Podcast #364 - In today's episode of The Habitat Podcast, we are back in the studio with our good friends Erich Long and Cody Altizer! We discuss: Managing for grouse improves deer habitat across the entire property Grouse are specialists; deer benefit from the habitat they require Forest health is the foundation of all successful wildlife management Everything done for grouse benefits whitetails, not the other way around Deer thrive as generalists; grouse expose weak habitat Young forest habitat benefits deer, turkeys, birds, and pollinators Invasive species quietly destroy forest-floor wildlife habitat Responsible logging creates life, not destruction Managing from the forest floor up changes everything Grouse are a gateway species for better land stewardship And So Much More! Shop the new Amendment Collection from Vitalize Seed here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://vitalizeseed.com/collections/new-natural-amendments ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ PATREON - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon - Habitat Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Brand new HP Patreon for those who want to support the Habitat Podcast. Good luck this Fall and if you have a question yourself, just email us @ info@habitatpodcast.com -------------------------------------------------------------------------- ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon - Habitat Podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Latitude Outdoors - Saddle Hunting: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/hplatitude⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Stealth Strips - Stealth Outdoors: Use code Habitat10 at checkout ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/stealthstripsHP⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Midwest Lifestyle Properties - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/3OeFhrm⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Vitalize Seed Food Plot Seed - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/vitalizeseed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Down Burst Seeders - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/downburstseeders⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 10% code: HP10 Morse Nursery - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/MorseTrees⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 10% off w/code: HABITAT10 Packer Maxx - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/PACKERMAXX⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ $25 off with code: HPC25 First Lite - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/3EDbG6P⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ LAND PLAN Property Consultations – HP Land Plans: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LAND PLANS⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Leave us a review for a FREE DECAL - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://apple.co/2uhoqOO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Morse Nursery Tree Dealer Pricing – info@habitatpodcast.com Habitat Podcast YOUTUBE - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCmAUuvU9t25FOSstoFiaNdg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email us: info@habitatpodcast.com habitat management / deer habitat / food plots / hinge cut / food plot Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Ben Jones, CEO of RGS & AWS, joins us to explore how active forest stewardship - from prescribed fire to targeted timber harvests and new wood markets - can restore age-class diversity and habitat for ruffed grouse and wild turkey across eastern forests.   Resources: EQUIP Food Plots, Feed or Fire: The Real Costs Per Pound of Deer Forage (NDA article) Ruffed Grouse Society   Dr. Ben Jones benj@ruffedgrousesociety.org   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   Coming Soon: Wild Turkey Manager: Biology, History, & Heritage! Our newest online wild turkey training is launching soon! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Donate to our wild turkey research: UF Turkey Donation Fund , Auburn Turkey Donation Fund    Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak  

Dr. Ben Jones, CEO of RGS & AWS, joins us to explore how active forest stewardship - from prescribed fire to targeted timber harvests and new wood markets - can restore age-class diversity and habitat for ruffed grouse and wild turkey across eastern forests.   Resources: EQUIP Food Plots, Feed or Fire: The Real Costs Per Pound of Deer Forage (NDA article) Ruffed Grouse Society   Dr. Ben Jones benj@ruffedgrousesociety.org   Our lab is primarily funded by donations. If you would like to help support our work, please donate here: http://UFgive.to/UFGameLab   We've launched our SECOND online training course focused on wild turkey biology, history, and heritage! Be the first to know when our new course launches by signing up here!   Be sure to check out our comprehensive online wild turkey course featuring experts across multiple institutions that specialize in habitat management and population management for wild turkeys. Earn up to 20.5 CFE hours! Enroll Now!    Dr. Marcus Lashley @DrDisturbance, Publications Dr. Will Gulsby @dr_will_gulsby, Publications Turkeys for Tomorrow @turkeysfortomorrow  UF Game Lab @ufgamelab, YouTube   Donate to our wild turkey research: UF Turkey Donation Fund , Auburn Turkey Donation Fund    Want to help wild turkey conservation? Please take our quick survey to take part in our research!   Do you have a topic you'd like us to cover? Leave us a review or send us an email at wildturkeyscience@gmail.com!   Watch these podcasts on YouTube   Please help us by taking our (quick) listener survey - Thank you!    Check out the DrDisturbance YouTube channel! DrDisturbance YouTube   Want to help support the podcast? Our friends at Grounded Brand have an option to donate directly to Wild Turkey Science at checkout. Thank you in advance for your support!   Leave a podcast rating for a chance to win free gear!   This podcast is made possible by Turkeys for Tomorrow, a grassroots organization dedicated to the wild turkey. To learn more about TFT, go to turkeysfortomorrow.org.    Music by Artlist.io Produced & edited by Charlotte Nowak  

If it were not for these dedicated organizations, we would have fewer birds and fewer places to chase them. From the eastern forests to the western prairies, RGS PF and NAGP work together on our behalf. Listen, learn and join up!!!

If you're looking to learn more about grouse and woodcock hunting from a bunch of seasoned vets who also relish giving each other a hard time, this episode is for you. Mike sat down with he crew of friends and fellow die-hard ruffed grouse and woodcock hunters to take on listener questions. Questions range from cover type, how they structure feeding schedule, how to be a better shot, and tips for taking your first trips to the northwoods. There is a ton to be learned from this episode. Enjoy!This episode is brought to you by Ugly Dog Hunting Co. Shop now at UglyDogHunting.comMusic used under Creative Commons -Two Step Daisy Duke by Mr. Smith is licensed under an Attribution 4.0 International License.

In this reload episode of The Birdshot Podcast, host Nick Larson delves into a lively Q&A session with a loyal listener, Brady Martin. As Brady embarks on his first season of serious grouse hunting with his new bird dog, he shares the challenges, questions, and experiences he's encountered. Together, they explore everything from scouting, bird cover, and hunting techniques to managing expectations for new hunters and bird dogs. Brady Martin is a first-time grouse hunter getting serious about the sport with his young bird dog. From his background in law enforcement and K-9 handling to his transition into upland bird hunting, Brady brings a unique perspective on both the joy and the challenges of pursuing ruffed grouse and woodcock. With a strong curiosity and desire to learn, he's asking all the right questions as he embarks on this new adventure. Expect to Learn How to effectively scout and assess grouse hunting spots using e-scouting tools Why early-season grouse hunting can be particularly challenging How Brady is training his young bird dog and what he's learning in the process Tips for understanding the nuances of grouse and woodcock cover The importance of adjusting your approach based on bird behavior and cover changes  Episode Breakdown with Timestamps: [00:00:00] - Introduction and Thank You to Patreons [00:08:57] - Poodle Pointer [00:16:39] - Nick's Journey [00:18:14] - First Question: Scouted Spots You Drive Past [00:28:52] - Is It Just Grouse or Woodcock Too? [00:32:35] - Early Season Challenges: Leaves, Food, or Scattered Birds? [00:52:25] - Hazel Brush [00:57:14] - Good Grouse Cover: White Pine, Hazel, and Swamps [01:17:29] -  Personality and Patience in Hunting and Fishing [01:28:05] - Handling a Dog on Point: Whoa or Let Them Learn? [01:32:57] - Last Question: Dog Training Helping a Dog Hunt Out of Sight Follow the Host Nick: Instagram: @birdshot.podcast Website: www.birdshotpodcast.com Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshot.podcast SUPPORT | http://www.patreon.com/birdshotUse Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

At Superior Upland's rustic ruffed grouse camp in the UP of Michigan, Travis Frank and a crew of passionate bird hunters share stories from the Northwoods.  We discuss current ruffed grouse hunting conditions and what to look for to find birds now through the end of season, the woodcock migration, breaking down habitat, creating grouse hunting habitat, the beauty of grouse camp, life of a grouse guide, from the White House to the Northwoods, Women in the Woods, smells from the forest, and so much more… @superior_upland.   Presented by: Walton's (waltons.com/) OnX Maps (onxmaps.com/) Aluma Trailers (alumaklm.com) GAIM Hunting & Shooting Simulator (https://alnk.to/74wKReb) Hunt Huron (HuntHuronsd.com), Federal Premium Ammunition (federalpremium.com/) Hunt North Dakota (helloND.com/) Lucky Duck Premium Decoys (luckyduck.com/) & Samaritan Tire (samaritantire.com/)

Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common forms of muscular dystrophy, affecting individuals across the lifespan with variable severity. Advances in genetic understanding and therapeutic development have led to an era of promising disease-modifying strategies. In this episode, Katie Grouse, MD FAAN, speaks with Renatta N. Knox, MD, PhD, author of the article “Facioscapulohumeral Muscular Dystrophy” in the Continuum® October 2025 Muscle and Neuromuscular Junction Disorders issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Knox is an assistant professor of neurology in the Division of Pediatric Neurology and Neuromuscular Section at Washington University School of Medicine in St. Louis, Missouri. Additional Resources Read the article: Facioscapulohumeral Muscular Dystrophy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN  Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Renatta Knox about her article on fascioscapulohumeral muscular dystrophy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Welcome to the podcast, and please introduce yourself to our audience. Dr Knox: Hi Katie, thank you so much for the invitation for the audio interview. I'm looking forward to our conversation. As she mentioned, my name is Renata Knox. It's a pleasure to be here today. Dr Grouse: I'd like to start by asking, what is the key message that you hope your readers will take from your article? Dr Knox: I would say two things. The first is an appreciation and understanding of the unique genetic mechanism that leads to FSHD. And the second is the really exciting therapy landscape that we find ourselves in. So, we're hopeful that there will actually be disease-modifying therapies for FSHD soon. Dr Grouse: We're really looking forward to learning more about that. Now, before we get to that piece, could you just remind us of the clinical manifestations and features that are specific to FSHD? Dr Knox: So, one of the most unique things about FSHD that we see clinically is the pattern of weakness. So, one of the first features is that it's asymmetric. And then there are certain muscle groups that typically are affected, and that's partly where the name comes from. So, we see effects in the face, the limbs, the trunk; and so, those are some of the unique features that we see clinically. Dr Grouse: I'd love it if you could walk us through how you approach diagnosing a patient who presents with proximal weakness where FSHD is in your differential. Dr Knox: Yeah, it's a really great question. So, I would say it depends. So, I actually focus on FSHD in my clinical practice. So, many times patients are referred to me because there's a very high suspicion or there's a known family history of FSHD. So, that's one category of cases. I would say the other category of case is where it's, as you said, maybe more proximal weakness more broadly. Someone that's before me who has a known family history, they really have some of the characteristic physical features---which I'm pretty attuned to, as this is, you know, part of my subspecialty---I'll actually go directly to FSHD genetic testing. And that is one of the unique features of this disease, that the next-generation sequencing panels that are typically used for some of our other muscle diseases, FSHD is not captured on those. So, we actually have to send targeted testing for FSHD to diagnose it. So, that is one category where, again, I have a very high suspicion either based on their clinical presentation and/or a known family history, then I will actually go directly to FSHD-targeted genetic testing. In the second case, where it is one of the conditions that I'm considering among others, I will do more broad testing. So, I will get a CK level to see if there's evidence of muscle breakdown. I'll likely also do one of the next-generation sequencing panels that we have access to, which will allow us to identify, potentially, one to two hundred potential muscle diseases. And then again, if FSHD is higher on my differential in that second group of patients, then I will also send targeted FSHD-specific testing. Dr Grouse: That's really helpful. And I'm wondering if you have any thoughts about common pitfalls that you've seen when providers are trying to work this up? Dr Knox: I don't know if I would say pitfalls. I think I would acknowledge that it's challenging. My subspecialty training in neuromuscular medicine and also gene therapy. And so FSHD is pretty high on my radar. But I would say in neurology in general---and then, you know, the general medical population---,it really isn't something that many people are seeing. So, I would say what patients will communicate to us sometimes is some frustration that maybe it took time to make the diagnosis, but I just have a deep understanding that it's not something that is on many people's radars. And I think, again, it's tricky because it's not picked up on these next-generation sequencing panels, which many of us can send pretty easily. It will be missed. And I will say the biggest pitfall is, again, if you're not thinking about it and you don't send that testing, you actually- it's very difficult to diagnose it. Dr Grouse: Thank you so much for highlighting that. I think there are many people who are not aware that those different panels really aren't picking that up and that they have to test specifically. So, I think that's a great thing for all of us to keep in mind. Are there any tips or tricks to the diagnosis, other than the genetic issues that you mentioned, that sometimes can really bring this diagnosis to the forefront? Dr Knox: I think things that really tip me off to having a higher suspicion for FSHD is facial weakness that we can detect on our exam. Scapular winging---again, there's a small subset of disorders which can impact that. Someone who's presenting with foot drop, you know, with facial weakness, I think definitely about FSHD more. Also, clinically, kind of the presentation or things that they're beginning to have difficulty with is a tip-off. So, if someone is an athlete, like, they're a volleyball player or basketball player and they say, oh, I'm having difficulties, you know, with movements that require them to elevate their arm, which can be a sign of the shoulder weakness that we classically see. Or someone who says, oh, I'm having a harder time shampooing my hair or combing my hair. So those can be tip-offs again, which are basically referencing the type of weakness that they have. Another feature of FSHD which isn't necessarily as broadly appreciated is that pain and fatigue are very common. So, if someone is coming in and saying, actually, I also have a significant amount of fatigue as well or a lot of pain, that's something that can tip me off to it. Hearing loss is something that we can also see in up to 20% of patients with FSHD. So, if they are having those symptoms or saying they're ringing in their ears, these are some things that will make me begin to think about it more. Dr Grouse: Oh, really helpful. I also found it really fascinating reading some of the very FSHD-specific clinical signs, some interesting- some diagrams and pictures as well, that are very specific to the pattern of weakness that develops in FSHD. So, I encourage our listeners to check that out. But are there any highlights from those little clinical pearls that you'd like to point out? Dr Knox: I think the poly-hill sign---so, these are these literal hills that we can see in the shoulders of patients with FSHD---is pretty classic. Popeye arms, which is this older term that we still use that has to do with which muscle groups are preserved versus those that have atrophy. So that's a common feature. And then I would say, really, the asymmetry is something that is a unique feature in FSHD. And again, we did our best to provide good representative images. So again, as you mentioned, Katie, I would really encourage people to look at those images and then think about cases that they may have seen and how similar they are so they can begin to recognize those signs as well. Dr Grouse: Now going back to the genetic topic, the complex genetic underpinnings of FSHD are really well-explained in your article; and again, worth taking a look at to remind ourselves of everything that's of that pathology. Now, I was wondering though, if you could give us a brief overview of how we should approach genetic testing in a suspected case of FSHD? You mentioned some specific panels, but it does sound like there's some more complexity to it as well. Dr Knox: Yes, and I'll just kind of briefly explain that complexity. Part of the thing that we're detecting in the genetic testing is the repeat number. And so, we're actually looking for a contraction in a repeat number. So, not an expansion, which were typical for some of the diseases that we think about, the trinucleotide repeat disorders. And this is why it's not captured in the next-generation sequencing panels, because they do not currently have the ability to do that. And so, again, what the type of testing that I do really depends on my suspicion. So again, if my suspicion is very high for FSHD---they have a family history, they have the classic features---then I will actually go directly to an FSHD-specific testing, which is available from various sources. If, again, it's among different things that I'm thinking about, I will get a CK lab. I typically will also send a next-generation sequencing panel specific for muscle diseases, perhaps muscular dystrophy; again, depending on what I'm thinking about. And then I will also send in a specific FSHD genetic test as well. People are beginning to use whole-genome sequencing, which is capturing some of our true nucleotide repeat disorders and becoming more comprehensive. So, my hope is that as that becomes more standard of care---like, whole-exome sequencing can be gotten pretty routinely now---that it may be easier for us to make some of these diagnoses. Dr Grouse: Well, that's really helpful, and thanks for that overview. Now another thing that you mentioned that I thought was really interesting in your article was that patients with, you know, history of FSHD, perhaps in the family, who are pregnant and want to screen for this disease would not be able to use sort of the more common screening tests like cell-free DNA testing and may have to go to other means to do that. What is generally their route to this type of testing? Dr Knox: Yeah, great question, and really important question for family planning purposes, and it definitely comes up in clinical practice. And so again, because of the unique genetics of FSHD, you actually have to do invasive genetic testing currently to be able to test it. And so that's, you know, amnio or chorio, and then send it to a lab that can perform, again, FSHD-specific testing on the samples that are presented. And there are obviously labs that are capable of doing that and centers that are capable of doing that, but it is not picked up on the cell-free DNA panels that are being very routinely used. You or your provider has to be thinking about it to send that specific testing, similar to our patients that come into clinic and have not yet been diagnosed. Dr Grouse: Once you have the diagnosis, what are our options for therapy? I think it sounds like at this current time, it looks to be mostly supportive. What are some of the supportive care options we should keep in mind? Dr Knox: Yes, so that is definitely accurate. Care today is supportive, but again, we're very excited about the clinical trial and therapy landscape for FSHD. So, I work very closely with my physical therapy colleagues that are in clinic with me. So, we work very closely with physical and occupational therapists to help with supportive measures, adaptive measures, doing assessments, helping our patients to be able to move and exercise safely and effectively. As I mentioned, pain is very common in FSHD and so we can treat that with medications. The most common medication that we use to treat for pain in FSHD are NSAIDs. And then other than that it's really, you know, supportive measures. Do they need to see other subspecialists? There are some surgical options. Those are used very rarely to help with some of the scapular weakness, but typically it's physical therapy, occupational therapy, supportive devices. We treat the pain as we're able to, and then we work with other subspecialists to screen, monitor and support our patients to the best of our ability. Dr Grouse: Well, without further ado, I'd love to hear more about what's coming down the pipeline in clinical trials. What can we look forward to seeing, hopefully, in future years to treat these patients? Dr Knox: Yes. And so, this is actually what got me interested in the neuromuscle space in general is that, because we now for many years have known the genetic cause of many of these disorders as well as some of the underlying mechanisms, we can actually use advances in therapeutics to do what we call targeted therapies. So, rather than treating symptoms or indirect methods or doing kind of broad drug screens---which, again, still do take place and still do have their place---we actually can target mechanisms directly. And so, we know that the underlying biology of FSHD is due to this protein called DUX4 being expressed when it should not be. So, it's what we call a toxic gain of function. And so, the targeted way to address this is to suppress DUX4 expression. And so, kind of broadly speaking, what we're really excited about are a couple of products that are currently in clinical trials right now that actually caused DUX4 suppression to be suppressed. And again, these are targeted pathways. And so, again, the hope is that by doing that, we can hopefully slow the progression of the disease, potentially stop progression of the disease, and potentially reverse. Again, we don't know if that might be possible, but that is one of the hopes. Dr Grouse: Well, that's really exciting, and I know we're all looking forward to more coming down the pipeline soon, and hopefully more things that can really offer some exciting treatments for our patients with this condition. Now, a little more deep-dive into our patients who are diagnosed. You've reviewed some of the treatments currently available and hopefully may someday soon be available. Are there other things that we should be keeping in mind in this population? For instance, screenings that we should be doing for other extramuscular manifestations that we need to be thinking about? Dr Knox: I will answer that question two ways. I think something that's very important to acknowledge is the impact that these diagnoses and these conditions have on our patient practically, psychologically. One of the other unique features of FSHD is, it's autosomal-dominant. So, if it is in a family, you can have many family members who are affected, but the variability is very high. And so, you can have in the same family someone who is wheelchair-dependent, and someone else in the family with the same underlying genetics who has no signs or symptoms or is very mildly affected. And that is something that is definitely challenging for our families and patients to navigate if they're very different than their family members with the same condition. And just navigating the world with a condition that, you know, can be physically debilitating and cause changes to what they're able to do or not able to do, progression is something that's very difficult to handle. So, I think that's one set of things. And we try our best, you know, with my team and my other colleagues in the space, to support our families and patients in the best way that we can. Secondly, there is very important screening that needs to be done for this condition. So, one of the things- and the current guidelines which are actually being updated, the last update was in 2015 is all patients that undergo pulmonary function testing or PFTs. And so that's something we do at baseline and we do at least annually in my practice. Young kids who are presenting very early or patients with certain genetics that we know are more predisposed to extra muscular manifestations, we recommend screening for hearing, which is one of the manifestations, and ophthalmologic exam to look for retinovascular changes, which is one of the manifestations as well. Those are the more common ones that are typically done. There's also some evidence in pediatric patients with very severe manifestations that there may be some cognitive impacts, learning impacts. And so, that is something we're also thinking about screening and supporting our patients in that way. And again, we typically work with these patients in a multidisciplinary team depending on what manifestations and the degrees to which they're impacted by the disorder. Dr Grouse: Thank you so much for that answer. I think a lot of us forget sometimes when we get really focused on what can we do now, that we forget to kind of stop and reflect on sort of the more holistic approach. How is this affecting the patient? How is this affecting the patient's family dynamic, and what other ways are they going through life with this condition that we need to be thinking about? So, I appreciate you bringing that up. I wanted to ask, sort of based on what you're talking about and what you mentioned already, you happened to mention that what initially drew you that to this work was your interest in some of the really exciting breakthroughs in the field. Well, was there anything else that drew you to, specifically, congenital neuromuscular diseases, and FSHD in particular? Dr Knox: I'm a physician scientist by training, and so I would describe myself also as a molecular biologist. So, I love getting into the nitty gritties of disease mechanisms, what genes are doing in bodies, how they function. And so, as I mentioned earlier, in the neuromuscle space, we've known for many years the genetic cause of many of these disorders and have done great, you know, mechanistic work to kind of define why we see the disease. And then now we're at this intersection of that knowledge marrying with these really novel therapeutic approaches, gene therapy approaches, being able to intersect and then in very creative ways actually target diseases very directly. And so, I would say it really is the combination of those two things. FSHD has a really fascinating unique biology, which again, we encourage everyone to read about more in the article. That really drew me to it. I'm very interested in gene regulation, transcription. This is one of the underlying mechanisms that is gone awry in the disorder, and then that being married to advances in therapeutics. So, you could wed those two pieces of information and actually meaningfully impact patient 's lives. And again, that's the real privilege and honor to witness is how these therapies can transform lives. And I saw it happened with this one case for this one disorder when I was a resident where there was no treatment. Young children, unfortunately, would not survive the disease. And then I saw the therapy come be in development and literally change the trajectory. And this is what we're very hopeful for in the FSHD space, that wedding, this wonderful basic science research, translational research, companies working together to develop these therapies that can transform lives. It is just so beautiful to witness and see, and it's something that I get to do. You know, it's a part of my job, so it's a real privilege. Dr Grouse: Well, I have to say, it's really inspiring hearing you talk about it. And I imagine that many neurologists-in-training who are listening to this may be inspired as well and may be convinced to go into this field for that very reason. So, thank you so much for sharing all of this information with us today. I learned a lot, and I think all of our listeners have too. Dr Knox: Thank you. It's really been a pleasure. Dr Grouse: Again, today I've been interviewing Dr Renatta Knox about her article on fascioscapulohumeral muscular dystrophy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Author (Building a Grouse Dog), trainer, breeder, grouse guide and avid hunter, Craig Doherty is uniquely qualified to help us navigate the woods. We'll cover what we can do to help young dogs on early hunts, the right mental approach to dog behaviors, and where grouse and woodcock live during hunting season in the northeast. We'll cover food sources, cover types and what makes up a good covert. Craig will share training and shooting advice, dog handling tips and how to introduce young dogs to the woods. "Fix It" has another item for your hunting season to-do list; listeners sound off on management of their states' walk-in programs - you might find a new destination for later this season! And it's all brought to you by: HiVizSights.com, RuffLand Kennels, Mid Valley Clays and Shooting School, TrulockChokes, HiViz shooting systems, Pointer shotguns, Purina Pro Plan Sport and FindBirdHuntingSpots.com.

In this article, Zach Cason writes about dusky grouse behavior, habitat, and hunting strategies to optimize your chances for a successful dusky hunt.Use code PU20 and get 20% off onxhunt.com.Read more at projectupland.com.

Bob is a long time grouse hunter, dog trainer, and mentor. We put together a good set of questions and I really like these kinds of podcasts. Thank you to our sponsorsAspen Thicket Grouse Dogs aspenthicketgrousedogs.comPine Hill Gun Dogs phkscllc@gmail.comSecond Chance Bird dogs Wild Card Outfitters and Guide Service wildcardoutdoors.comPrairie ridge Farms prairieridgefarms.com

In this episode of The Birdshot Podcast, host Nick Larson is joined by Jon Steigerwaldt, a Forest Conservation Director for the Ruffed Grouse Society and American Woodcock Society. Jon talks about the critical habitat work happening in the Driftless Region and northeast Iowa, highlighting the challenges facing ruffed grouse populations, the impact of forest management, and ongoing conservation efforts. From habitat restoration to dealing with invasive species, this conversation covers key conservation strategies while also touching on Jon's experiences hunting and training his bird dog, Hazel. Jon Steigerwaldt is a dedicated conservationist and upland bird hunter with a deep background in forestry and forest ecology. With a focus on sustainable forest management, Jon works with multiple states across the Upper Midwest to improve habitats for ruffed grouse, woodcock, and other species. In his role with the Ruffed Grouse Society and American Woodcock Society, Jon is directly involved in large-scale projects to restore forest ecosystems and support wildlife populations in the Driftless Region and beyond. Expect to Learn The importance of forest management for ruffed grouse and other upland species How dynamic forest restoration blocks help improve habitat for grouse populations Challenges faced by forest management in the Driftless Region, including parcelization and topography The role of invasive species like multiflora rose and honeysuckle in disrupting habitat Jon's insights into training bird dogs like his setter, Hazel, and the role of dogs in upland hunting Current efforts to revitalize grouse populations in northeast Iowa and other parts of the Midwest Episode Breakdown with Timestamps: [00:00] - Introduction [04:00] - Nick's First Ruffed Grouse Hunt of the Year [10:22] - Jon's Bird Dog, Hazel, and How She's Developed Over the Years [11:32] - Jon's First Big Dog [13:33] - Jon's Career and Education [23:01] - Parcelization and Landowner Challenges in Logging [35:51] - Invasive Species and Their Impact on Forest Ecosystems [44:50] - Forest Management After Natural Disasters [50:13] - Stewardship Agreements and Reinvestment Into Forests [57:28] - Upcoming Events and Community Management Follow the Guest Jon: Ruffed Grouse Society: https://ruffedgrousesociety.org/  Instagram: https://www.instagram.com/ruffedgrousesociety/?hl=en  Fall Membership 2025: https://ruffedgrousesociety.org/  Follow the Host Nick: Instagram: @birdshot.podcast Website: www.birdshotpodcast.com Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshot.podcast SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of The Birdshot Podcast, Nick Larson welcomes Tom Carpenter, aka Carp, back to the show for a discussion on prairie grouse hunting and sharp-tail grouse hunting. Fresh off a couple of hunting trips, Tom shares his expertise and experiences in the Great Plains, hunting sharp-tails, prairie chickens, as well as the unique challenges of these beautiful birds. Carp also reflects on the joy of hunting with dogs and the importance of understanding grassland habitat for both the hunter and the bird. Tom Carpenter, affectionately known as Carp, is a seasoned bird hunter, author, and long-time advocate for prairie grouse. With decades of experience, Tom is passionate about hunting sharp-tails, prairie chickens, and other upland game birds across the Great Plains. He's spent countless days hunting with his bird dogs and has become a prominent voice in the upland hunting community, especially when it comes to prairie grouse. Expect to Learn Tom's experiences hunting prairie chickens in Minnesota and sharp-tails across the Midwest The best hunting strategies and terrain for finding prairie grouse Insights into managing a bird dog for prairie grouse hunting Tips on dog training during sharptail hunts and what makes prairie grouse hunting unique The importance of native grasses and proper grazing for the sharp-tailed habitatEpisode Breakdown with Timestamps: [00:00:00] - Introduction [00:06:18] - Success of hunting prairie chickens [00:10:01] - How prairie chickens differ from other upland birds  [00:14:09] - Difference between ankle-high grass, calf-high grass, and knee-high grass [00:22:15] - Have you ever put a snowberry in your mouth? [00:30:56] - How to train a bird dog [00:39:51] - Popcorn flushing  [00:42:49] - Breakdown of hills and wind direction [00:53:09] - Hunting in thick cover vs thinner hills [01:05:49] - Favorite sharp-tail recipe [01:16:42] -The pheasants forever journal [01:17:40] - Wrapping up the episode Follow the Guest Tom:  Tom as an Editor of Pheasants Forever: https://pheasantsforever.org/Newsroom/2018-April/Changing-of-the-Guard-Pheasants-Forever-Promotes-T.aspx  Company's Website: https://www.pheasantsforever.org  Company's Facebook: https://www.facebook.com/pheasantsforever  Company's Email: contact@pheasantsforever.org  Pheasant Hunting (book): https://amzn.to/46JZptD  Follow Host Nick: Instagram: @birdshot.podcast Website: www.birdshotpodcast.com Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshot.podcast SUPPORT | http://www.patreon.com/birdshotUse Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Tom Carpenter from Pheasants Forever & Quail Forever joins the show to break down the 2025 prairie grouse primer presented by Sportsman's Guide.  We break down sharp-tailed grouse, sage grouse, Hungarian partridge, and prairie chicken hunting expectations by region, from Idaho to Minnesota and places in between.  We discuss factors that raised bird counts in some places, and lowered counts in others.  We share details that can make or break your next hunt on the prairie and throw in a few tricks to outsmart those wild birds.  It's a full prairie grouse primer, with even more information @pheasantsforever   Presented by: Walton's (waltons.com/) OnX Maps (onxmaps.com/) Aluma Trailers (alumaklm.com) GAIM Hunting & Shooting Simulator (https://alnk.to/74wKReb) Compeer Home (compeerhome.com) Federal Premium Ammunition (federalpremium.com/) Hunt North Dakota (helloND.com/) Lucky Duck Premium Decoys (luckyduck.com/) & Samaritan Tire (samaritantire.com/)

Ecologist, guide, dog trainer, and taxidermist, Meadow Kouffeld, gives us a rundown on Ruffed Grouse biology and their habits. Knowing your quarry isn't just interesting, it will make you a better hunter. Quit grousing around and tune in for some great grouse info.As always, we want to hear your feedback! Let us know if there are any topics you'd like covered on the Vortex Nation™ podcast by asking us on Instagram @vortexnationpodcast

In this episode of the Birdshot Podcast, host Nick Larson welcomes Andy Wayment, a passionate upland bird hunter, fly fisherman, and bibliophile, to discuss some of the best books in the world of upland hunting and fly fishing. Their conversation spans timeless authors like Burton Spiller and Tom Davis, plus a special look at books like Irish Red and Big Red. Whether you're a bird hunter, fly fisherman, or just a lover of outdoor literature, this episode is sure to inspire your next reading list. Andy Wayment is an avid upland bird hunter, fly fisherman, and self-proclaimed book nerd. With years of experience in bird hunting and a deep appreciation for literature, Andy has curated an extensive collection of hunting and fishing books. He is particularly passionate about sharing his knowledge of the classic authors and hidden gems in the genre. Andy has also authored his own books on Idaho upland hunting, contributing to the literary world of bird hunting. Expect to Learn The best books on upland bird hunting, including Irish Red and Big Red. Insights into the connections between fly fishing and bird hunting literature. Hidden gems in bird hunting books, including works by Burton Spiller and Tom Davis. Why fly fishing books also attract hunters and how the two pursuits often intersect in literature. The upcoming release of Andy's own book, Idaho Grouse Fever, and what readers can expect. Episode Breakdown with Timestamps [00:00:00] - Introduction to Andy Wayment and His Love for Books [00:03:52] - Andy's Story as a fly fisherman [00:10:23] - The Connection Between Fly Fishing and Upland Hunting books [00:15:59] - Authors and their Qualifications [00:25:05] - Irish Red and Big Red by Jim Kjelgaard [00:36:47] - Best Birds by Worth Mathewson [00:42:55] - Andy's New Book [00:57:40] - No. 1 Book - Drummer in the Woods [01:03:58] - Hour+ of Book Recommendations and Closing Thoughts. Follow Andy Wayment  Instagram: https://www.instagram.com/andywayment/  Website: https://uplandways.com/ ANDY'S TOP FIVE FAVORITES:  1.  Drummer in the Woods, Burton Spiller  2.  Partridge Shortenin', Gorham Cross (Grampa Grouse) 3.  My Friend the Patridge, S.T. Hammond  4.  That's Ruff, George King 5.  Grouse Feathers, Again, Burton Spiller Runner's Up:  6.  Upland Days, William G. Tapply 7.  Upland Autumn, William G. Tapply  8.  A Passion for Grouse, anthology edited by Tom Pero ANDY'S PICKS FOR FAVORITE UPLAND FICTION 1.  A Millionaire's Dream, Brett Wannacott 2.  A High Lonesome Call, Robert Holthowzer 3.  Jenny Willow, Mike Gaddis  4.  Irish Red, Jim Kjelgaard 5.  The Dumbell of Brookfield, John Tainter Foote BOOKS WITH SOME BLUE GROUSE HUNTING 1.  Fool Hen Blues, E. Donnell Thomas, Jr.  2.  A Hunter's Road and The Sporting Road, Jim Fergus 3.  Plateaus of Destiny, Mike Gould 4.  Kicking Up Trouble, John Holt 5.  Grouse of North America: A Cross-Continental Hunting Guide, Tom Huggler 6.  Winston, Ben O. Williams 7.  Idaho Upland Days, Andrew Marshall Wayment  8.  Hunting Upland Birds, Charley Waterman  Follow Host Nick LinkedIn: https://www.linkedin.com/in/xnicklarsonx/ Website: www.birdshotpodcast.com Instagram: https://www.instagram.com/birdshot.podcast/?hl=en Listening Links: Spotify: https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts: https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube: http://www.youtube.com/@birdshotpodcast8302 SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of The Birdshot Podcast, host Nick Larson is joined by Mike Amman, a County Forester in Wisconsin, to discuss the evolving landscapes of the state's upland habitats, with a particular focus on sharp-tailed grouse populations, habitat management, and conservation efforts. Mike shares his extensive experience working with county forests, overseeing land management practices that support both wildlife conservation and sustainable forestry. This episode also focuses on Mike's involvement and the exciting developments surrounding a limited hunting season for sharp-tailed grouse this fall. Mike Amman is a County Forester with over 22 years of experience working in forest management across Wisconsin's public and private lands. His expertise includes habitat restoration, wildlife management, and timber production, particularly within the context of county forest systems. Mike is also an active board member of the Wisconsin Sharp-tailed Grouse Society, a group dedicated to the conservation of sharp-tailed grouse populations and the unique barrens habitat of northwest Wisconsin. His commitment to preserving wildlife habitats while balancing sustainable forestry practices makes him an invaluable resource for land management in the region. Expect to Learn How Mike Amman manages and conserves county forest land in Wisconsin. The role of prescribed burns and mechanical treatments in restoring and maintaining sharp-tailed grouse habitat. Insights into the Wisconsin Sharp-tailed Grouse Society and its conservation efforts. The impact of forest fragmentation and land ownership changes on wildlife habitat. Why sharp-tailed grouse populations are thriving in some areas and the challenges involved in maintaining sustainable harvests for hunting seasons. Episode Breakdown with Timestamps [00:00:00] - Introduction [00:01:36] - A Day in the Life of a County Forester [00:05:46] - Major Differences in the Forest over time [00:18:00] - Fabric from Wood Fiber- Tencel [00:29:12] - 100+ Dancing Males on a Lek [00:38:11] - Give or Take Event [00:42:18] - Trips Out West Spur Mike's Interest in Sharp-tailed Grouse [00:48:46] - Considerations for Bird Dog Training [00:52:32] - Observation Tool For Sharp-tailed Grouse Sightings [00:56:56] - Learn More about the onX Hunt WI Game Bird Layer [00:03:18] - How to Connect with Mike Follow Guest Mike LinkedIn: https://www.linkedin.com/in/mike-amman-a361a62a/ Instagram: https://www.instagram.com/grouseweims/ Wisconsin Sharp-tailed Grouse Society: https://www.wisharptails.org/ Follow Host Nick LinkedIn: https://www.linkedin.com/in/xnicklarsonx/ Website: www.birdshotpodcast.com Instagram: https://www.instagram.com/birdshot.podcast/?hl=en Listening Links Spotify:https://open.spotify.com/show/17EVUDJPwR2iJggzhLYil7 Apple Podcasts:https://podcasts.apple.com/us/podcast/birdshot-podcast/id1288308609 YouTube:http://www.youtube.com/@birdshotpodcast8302 SUPPORT | http://www.patreon.com/birdshot Use Promo Code | BSP20 to save 20% on https://www.onxmaps.com/hunt/app Use Promo Code | BS10 to save 10% on https://trulockchokes.com/ The Birdshot Podcast is Presented By: https://www.onxmaps.com/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Before we hit the microphone I asked Zach to walk my property to see what has happened in three the years since we logged our woods. I learned a lot! RGS/AWS is the shining star in the heavens we call home. Projects are popping up all over and the future is brite!!

Before we hit the microphone I asked Zach to walk my property to see what has happened in three the years since we logged our woods. I learned a lot! RGS/AWS is the shining star in the heavens we call home. Projects are popping up all over and the future is brite!!

Before we hit the microphone I asked Zach to walk my property to see what has happened in three the years since we logged our woods. I learned a lot! RGS/AWS is the shining star in the heavens we call home. Projects are popping up all over and the future is brite!!

Before we hit the microphone I asked Zach to walk my property to see what has happened in three the years since we logged our woods. I learned a lot! RGS/AWS is the shining star in the heavens we call home. Projects are popping up all over and the future is brite!!